Marcus Maurer
#94,131
Most Influential Person Now
Researcher
Marcus Maurer's AcademicInfluence.com Rankings
Marcus Maurercomputer-science Degrees
Computer Science
#3224
World Rank
#3377
Historical Rank
Machine Learning
#327
World Rank
#331
Historical Rank
Artificial Intelligence
#517
World Rank
#526
Historical Rank
Database
#681
World Rank
#715
Historical Rank
Download Badge
Computer Science
Marcus Maurer's Degrees
- Masters Computer Science Stanford University
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Marcus Maurer Influential?
(Suggest an Edit or Addition)Marcus Maurer's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. (2014) (1106)
- The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria (2018) (1014)
- Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. (2013) (805)
- EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria (2006) (690)
- Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report 1 (2011) (617)
- A comprehensive guide for the recognition and classification of distinct stages of hair follicle morphogenesis. (1999) (543)
- Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. (2010) (496)
- EAACI/GA²LEN/EDF/WAO guideline: management of urticaria (2009) (462)
- Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy. (2013) (460)
- EAACI/GA2LEN/EDF guideline: management of urticaria (2006) (451)
- Mast cells as sentinels of innate immunity. (1999) (408)
- Macrophage inflammatory protein-1. (2004) (393)
- The EAACI/GA 2 LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update (2015) (348)
- The international WAO/EAACI guideline for the management of hereditary angioedema—The 2017 revision and update (2018) (347)
- Mast Cells Can Secrete Vascular Permeability Factor/ Vascular Endothelial Cell Growth Factor and Exhibit Enhanced Release after Immunoglobulin E–dependent Upregulation of Fcε Receptor I Expression (1998) (344)
- How to assess disease activity in patients with chronic urticaria? (2008) (338)
- Risk of first‐generation H1‐antihistamines: a GA2LEN position paper (2010) (338)
- A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria. (2011) (329)
- Control of murine hair follicle regression (catagen) by TGF‐β1 in vivo (2000) (313)
- Mast cells promote homeostasis by limiting endothelin-1-induced toxicity (2004) (309)
- Impaired mast cell-dependent natural immunity in complement C3-deficient mice (1997) (300)
- Mast cells--key effector cells in immune responses. (2007) (298)
- Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase. (2011) (295)
- Mast cells are required for normal healing of skin wounds in mice (2006) (293)
- Epidemiology of urticaria: a representative cross‐sectional population survey (2010) (289)
- EAACI/GA2LEN task force consensus report: the autologous serum skin test in urticaria (2009) (271)
- Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology. (2016) (258)
- Development and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing urticaria control. (2014) (258)
- WAO Guideline for the Management of Hereditary Angioedema (2012) (249)
- Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus. (2006) (244)
- The definition, diagnostic testing, and management of chronic inducible urticarias – The EAACI/GA2LEN/EDF/UNEV consensus recommendations 2016 update and revision (2016) (241)
- EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria (2006) (241)
- Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis. (2014) (232)
- Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. (2012) (224)
- Omalizumab for the treatment of chronic spontaneous urticaria: A meta-analysis of randomized clinical trials. (2016) (223)
- The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria. (2015) (222)
- IgE Mediated Autoallergy against Thyroid Peroxidase – A Novel Pathomechanism of Chronic Spontaneous Urticaria? (2011) (217)
- Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity (2006) (216)
- What is the physiological function of mast cells? (2003) (213)
- Schnitzler's syndrome: diagnosis, treatment, and follow‐up (2013) (210)
- Autoimmune chronic spontaneous urticaria: What we know and what we do not know (2017) (205)
- Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study (2014) (204)
- Mast cells as initiators of immunity and host defense (2001) (202)
- Characterization of functional vanilloid receptors expressed by mast cells. (1998) (196)
- Successful treatment of solar urticaria with anti‐immunoglobulin E therapy (2008) (190)
- The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria (2021) (188)
- The burden of chronic spontaneous urticaria is substantial: Real‐world evidence from ASSURE‐CSU (2017) (187)
- Pharmacology of Antihistamines (2011) (184)
- NMR solution structure of a complex of calmodulin with a binding peptide of the Ca2+ pump. (1999) (183)
- Diagnosis and Treatment of Urticaria and Angioedema: A Worldwide Perspective (2012) (178)
- MACVIA‐ARIA Sentinel NetworK for allergic rhinitis (MASK‐rhinitis): the new generation guideline implementation (2015) (178)
- High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. (2009) (177)
- TLR3-induced activation of mast cells modulates CD8+ T-cell recruitment. (2005) (177)
- EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria (2013) (172)
- Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence (2017) (172)
- IL-9 Production by Regulatory T Cells Recruits Mast Cells That Are Essential for Regulatory T Cell-Induced Immune Suppression (2011) (162)
- Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria. (2017) (159)
- The c-kit Ligand, Stem Cell Factor, Can Enhance Innate Immunity Through Effects on Mast Cells (1998) (158)
- The definition and diagnostic testing of physical and cholinergic urticarias – EAACI/GA2LEN/EDF/UNEV consensus panel recommendations (2009) (155)
- Development and construct validation of the angioedema quality of life questionnaire (2012) (153)
- Mast cells orchestrate type 2 immunity to helminths through regulation of tissue-derived cytokines (2012) (152)
- Rupatadine in allergic rhinitis and chronic urticaria (2008) (151)
- The role of IL-33 and mast cells in allergy and inflammation (2015) (151)
- Urticaria: current opinions about etiology, diagnosis and therapy. (2007) (151)
- Prevalence of chronic urticaria in children and adults across the globe: Systematic review with meta‐analysis (2020) (150)
- The German version of the chronic urticaria quality‐of‐life questionnaire: factor analysis, validation, and initial clinical findings (2009) (149)
- New topics in bradykinin research (2011) (148)
- Ligelizumab for Chronic Spontaneous Urticaria. (2019) (144)
- Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis (2014) (144)
- Factors responsible for differences between asymptomatic subjects and patients presenting an IgE sensitization to allergens. A GA2LEN project (2006) (143)
- IL‐24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria (2017) (142)
- p53 is essential for chemotherapy-induced hair loss. (2000) (141)
- Anti-Immunoglobulin E Treatment of Patients with Recalcitrant Physical Urticaria (2010) (140)
- Pattern analysis of human cutaneous mast cell populations by total body surface mapping (2003) (140)
- Mast cell involvement in murine hair growth. (1994) (138)
- International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency (2016) (138)
- Undertreatment of rhinitis symptoms in Europe: findings from a cross‐sectional questionnaire survey (2007) (138)
- Skin mast cells control T cell‐dependent host defense in Leishmania major infections (2006) (137)
- Development, validation, and initial results of the Angioedema Activity Score (2013) (136)
- Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial (2018) (134)
- The clinical response to omalizumab in chronic spontaneous urticaria patients is linked to and predicted by IgE levels and their change (2018) (133)
- Early macrophage influx to sites of cutaneous granuloma formation is dependent on MIP-1alpha /beta released from neutrophils recruited by mast cell-derived TNFalpha. (2003) (131)
- Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study. (2015) (131)
- International consensus on hereditary and acquired angioedema. (2012) (131)
- Retreatment with omalizumab results in rapid remission in chronic spontaneous and inducible urticaria. (2014) (130)
- Mast cells promote Th1 and Th17 responses by modulating dendritic cell maturation and function (2011) (130)
- Successful treatment of cholinergic urticaria with anti‐immunoglobulin E therapy (2008) (129)
- Autologous Whole Blood Injections to Patients with Chronic Urticaria and a Positive Autologous Serum Skin Test: A Placebo-Controlled Trial (2006) (128)
- The role and relevance of mast cells in urticaria (2018) (126)
- Molecular targets on mast cells and basophils for novel therapies. (2014) (125)
- ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle (2016) (124)
- Hereditary Angioedema Attacks Resolve Faster and Are Shorter after Early Icatibant Treatment (2013) (124)
- Impaired mast cell development and innate immunity in Mac-1 (CD11b/CD18, CR3)-deficient mice. (1998) (122)
- Mast cell functions in the innate skin immune system. (2008) (119)
- IL-15 constrains mast cell–dependent antibacterial defenses by suppressing chymase activities (2007) (119)
- A simple immunofluorescence technique for simultaneous visualization of mast cells and nerve fibers reveals selectivity and hair cycle – dependent changes in mast cell – nerve fiber contacts in murine skin (1997) (119)
- Hereditary angioedema with C1 inhibitor deficiency: delay in diagnosis in Europe (2013) (114)
- Comorbidity of chronic spontaneous urticaria and autoimmune thyroid diseases: A systematic review (2017) (113)
- High prevalence of mental disorders and emotional distress in patients with chronic spontaneous urticaria. (2011) (113)
- Effect of omalizumab on angioedema in H1‐antihistamine‐resistant chronic spontaneous urticaria patients: results from X‐ACT, a randomized controlled trial (2016) (110)
- Acquired cold urticaria: clinical picture and update on diagnosis and treatment (2007) (110)
- Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata). (2007) (108)
- Activated skin mast cells are involved in murine hair follicle regression (catagen). (1997) (108)
- Immunoglobulin E-Mediated Autoimmunity (2018) (108)
- Recommendations for assessing Patient‐Reported Outcomes and Health‐Related quality of life in clinical trials on allergy: a GA2LEN taskforce position paper (2010) (108)
- Immediate contact skin reactions, an update of Contact Urticaria, Contact Urticaria Syndrome and Protein Contact Dermatitis -- "A Never Ending Story". (2010) (107)
- Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands (2009) (106)
- Migration of Melanoblasts into the Developing Murine Hair Follicle Is Accompanied by Transient c-Kit Expression (2002) (104)
- Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin (2017) (104)
- Up-dosing with bilastine results in improved effectiveness in cold contact urticaria (2013) (103)
- Autoimmune comorbidity in chronic spontaneous urticaria: A systematic review. (2017) (103)
- Chronic urticaria: an internet survey of health behaviours, symptom patterns and treatment needs in European adult patients (2009) (103)
- A Role for CD21/CD35 and CD19 in Responses to Acute Septic Peritonitis: A Potential Mechanism for Mast Cell Activation1 (2000) (102)
- SARS-CoV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itself (2021) (102)
- The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update (2022) (102)
- Interleukin‐31 does not induce immediate itch in atopic dermatitis patients and healthy controls after skin challenge (2014) (101)
- Hair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia. (1997) (100)
- Effects of a pseudoallergen‐free diet on chronic spontaneous urticaria: a prospective trial (2010) (99)
- Elevations in T‐helper‐2‐initiating cytokines (interleukin‐33, interleukin‐25 and thymic stromal lymphopoietin) in lesional skin from chronic spontaneous (‘idiopathic’) urticaria (2015) (99)
- Efficacy and safety of the interleukin‐1 antagonist rilonacept in Schnitzler syndrome: an open‐label study (2012) (98)
- The role of the IL-33/IL-1RL1 axis in mast cell and basophil activation in allergic disorders. (2015) (98)
- Mast Cells as Drivers of Disease and Therapeutic Targets. (2017) (96)
- Omalizumab is effective in cold urticaria-results of a randomized placebo-controlled trial. (2017) (96)
- How best to fight that nasty itch – from new insights into the neuroimmunological, neuroendocrine, and neurophysiological bases of pruritus to novel therapeutic approaches (2005) (96)
- Is diet partly responsible for differences in COVID-19 death rates between and within countries? (2020) (96)
- Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells (2021) (95)
- Hair cycle-dependent changes in adrenergic skin innervation, and hair growth modulation by adrenergic drugs. (1999) (95)
- Control of Pseudomonas aeruginosa skin infections in mice is mast cell-dependent. (2007) (95)
- Evaluating the minimally important difference of the urticaria activity score and other measures of disease activity in patients with chronic idiopathic urticaria. (2012) (94)
- Chronic spontaneous urticaria in children: Itching for insight (2011) (94)
- Melanogenesis During the Anagen-Catagen-Telogen Transformation of the Murine Hair Cycle (1994) (94)
- Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study (2019) (94)
- Severe Chronic Allergic (and Related) Diseases: A Uniform Approach – A MeDALL – GA2LEN – ARIA Position Paper (2012) (93)
- Physical urticarias and cholinergic urticaria. (2014) (92)
- Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies (2018) (91)
- Urticaria: Collegium Internationale Allergologicum (CIA) Update 2020 (2020) (90)
- H1‐antihistamine‐refractory chronic spontaneous urticaria: it's worse than we thought – first results of the multicenter real‐life AWARE study (2017) (89)
- Definition, aims, and implementation of GA2LEN Urticaria Centers of Reference and Excellence (2016) (89)
- Sleep and allergic rhinitis. (2008) (89)
- The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo‐ controlled treatment with rupatadine 10 and 20 mg (2009) (88)
- Melanogenesis during the anagen-catagen-telogen transformation of the murine hair cycle. (1993) (88)
- Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria. (2014) (87)
- Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology (2019) (87)
- Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica (2008) (84)
- Cyclosporine for Chronic Spontaneous Urticaria: A Meta-Analysis and Systematic Review. (2017) (82)
- The global burden of chronic urticaria for the patient and society * (2020) (81)
- The role of interleukin-1 in allergy-related disorders (2012) (81)
- The role of mast cells in neuroinflammation (2013) (81)
- Recommendations for assessing patient‐reported outcomes and health‐related quality of life in patients with urticaria: a GA2LEN taskforce position paper (2011) (80)
- Mast cell-driven skin inflammation is impaired in the absence of sensory nerves. (2008) (80)
- Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma (2019) (80)
- Schröder gegen Stoiber : Nutzung, Wahrnehmung und Wirkung der TV-Duelle (2003) (79)
- Chronic spontaneous urticaria and internal parasites – a systematic review (2016) (79)
- Elevations in vascular markers and eosinophils in chronic spontaneous urticarial weals with low-level persistence in uninvolved skin (2014) (78)
- A simultaneous 15N,1H- and 13C,1H-HSQC with sensitivity enhancement and a heteronuclear gradient echo (1995) (78)
- Role of mast cells in experimental anti‐glomerular basement membrane glomerulonephritis (2005) (78)
- Mast cells rescue implantation defects caused by c-kit deficiency (2013) (77)
- From seafood waste to active seafood packaging: An emerging opportunity of the circular economy (2019) (77)
- p53 Involvement in the control of murine hair follicle regression. (2001) (77)
- How not to miss autoinflammatory diseases masquerading as urticaria (2012) (77)
- Physical Urticaria (2012) (77)
- Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema (2018) (76)
- Omalizumab in chronic urticaria (2012) (75)
- Chronic urticaria: a patient survey on quality‐of‐life, treatment usage and doctor–patient relation (2009) (75)
- Schröder gegen Stoiber (2003) (75)
- The Angioedema Quality of Life Questionnaire (AE‐QoL) – assessment of sensitivity to change and minimal clinically important difference (2016) (74)
- Successful treatment of delayed pressure urticaria with anti-TNF-alpha. (2007) (74)
- Potential blood biomarkers in chronic spontaneous urticaria (2017) (74)
- Omalizumab is effective in symptomatic dermographism-results of a randomized placebo-controlled trial. (2017) (73)
- Efficacy and safety of canakinumab in Schnitzler syndrome: A multicenter randomized placebo‐controlled study (2017) (72)
- The XTEND‐CIU study: Long‐term use of omalizumab in chronic idiopathic urticaria (2017) (72)
- Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA2LEN taskforce position paper (2010) (71)
- The Urticaria Activity Score-Validity, Reliability, and Responsiveness. (2017) (69)
- Frequency and clinical implications of skin autoreactivity to serum versus plasma in patients with chronic urticaria. (2009) (69)
- Revisions to the international guidelines on the diagnosis and therapy of chronic urticaria (2013) (69)
- Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumab. (2010) (67)
- Mast cells as modulators of hair follicle cycling (1995) (67)
- Similar Efficacy with Omalizumab in Chronic Idiopathic/Spontaneous Urticaria Despite Different Background Therapy. (2015) (66)
- Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients (2009) (66)
- Executive summary of the methods report for ‘The EAACI/GA2LEN/EDF/WAO Guideline for the Definition, Classification, Diagnosis and Management of Urticaria. The 2017 Revision and Update’ (2018) (66)
- [WAO Guideline for the Management of Hereditary Angioedema]. (2015) (66)
- Total IgE levels are linked to the response of chronic spontaneous urticaria patients to omalizumab (2018) (65)
- The role of innate immunity in asthma: leads and lessons from mouse models (2007) (65)
- Eosinopenia, in chronic spontaneous urticaria, is associated with high disease activity, autoimmunity and poor response to treatment. (2019) (65)
- A Review of International Recommendations for the Diagnosis and Management of Chronic Urticaria. (2017) (64)
- Hereditary angioedema: molecular and clinical differences among European populations. (2015) (64)
- Omalizumab – an effective and safe treatment of therapy‐resistant chronic spontaneous urticaria (2011) (64)
- Misdiagnosis trends in patients with hereditary angioedema from the real-world clinical setting. (2016) (64)
- Complete remission in 3 of 3 anti-IL-6-treated patients with Schnitzler syndrome. (2012) (64)
- Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria. (2010) (63)
- Responsiveness and minimal important difference of the urticaria control test (2017) (63)
- Topical sodium cromoglicate relieves allergen‐ and histamine‐induced dermal pruritus (2010) (63)
- Who is really in control of skin immunity under physiological circumstances – lymphocytes, dendritic cells or keratinocytes? (2006) (63)
- Murine skin as a target for melatonin bioregulation (1994) (62)
- Management of chronic spontaneous urticaria in real life – in accordance with the guidelines? A cross‐sectional physician‐based survey study (2013) (62)
- Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: Analyses from ASSURE‐CSU (2018) (62)
- Innate immunity and allergy in the skin. (2009) (61)
- Pharmacological disruption of hair follicle pigmentation by cyclophosphamide as a model for studying the melanocyte response to and recovery from cytotoxic drug damage in situ. (1996) (61)
- Erratum: Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: A randomized, placebo-controlled study (Journal of Investigative Dermatology (2015) 135 (67-75)) DOI: 10.1038/jid.2014.306) (2015) (61)
- New treatments for chronic urticaria. (2019) (61)
- The mast cell products histamine and serotonin stimulate and TNF-alpha inhibits the proliferation of murine epidermal keratinocytes in situ. (1997) (60)
- Management and treatment of chronic urticaria (CU) (2015) (59)
- Kit is expressed by epithelial cells in vivo. (2003) (59)
- Mast cells: makers and breakers of allergic inflammation (2009) (59)
- Lesions on the back of hands and female gender predispose to stigmatization in patients with psoriasis (2017) (59)
- Chronic inducible urticaria: A systematic review of treatment options (2018) (59)
- Peltier effect-based temperature challenge: an improved method for diagnosing cold urticaria. (2004) (59)
- Successful treatment of cutaneous mastocytosis and Ménière disease with anti-IgE therapy. (2007) (59)
- A randomized trial of quilizumab in adults with refractory chronic spontaneous urticaria. (2016) (58)
- Mast Cell Promotion of T Cell–Driven Antigen‐Induced Arthritis Despite Being Dispensable for Antibody‐Induced Arthritis in Which T Cells Are Bypassed (2015) (57)
- Substance P stimulates murine epidermal keratinocyte proliferation and dermal mast cell degranulation in situ (2004) (57)
- Mast cells protect from post‐traumatic brain inflammation by the mast cell‐specific chymase mouse mast cell protease‐4 (2013) (57)
- Practical algorithm for diagnosing patients with recurrent wheals or angioedema (2013) (56)
- Comorbidity and pathogenic links of chronic spontaneous urticaria and systemic lupus erythematosus – a systematic review (2016) (55)
- Microbiota‐dependent and ‐independent effects of dietary fibre on human health (2020) (55)
- Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic / Spontaneous Urticaria Who Remain Symptomatic on H 1 Antihistamines : A Randomized , Placebo-Controlled Study (2010) (55)
- Substance P is upregulated in the serum of patients with chronic spontaneous urticaria. (2014) (55)
- Cross-correlated relaxation for the measurement of angles between tensorial interactions. (2000) (55)
- Results and relevance of critical temperature threshold testing in patients with acquired cold urticaria (2010) (55)
- C‐reactive protein is linked to disease activity, impact, and response to treatment in patients with chronic spontaneous urticaria (2018) (54)
- Update on rupatadine in the management of allergic disorders (2015) (54)
- Critical role of IL-10 in the induction of low zone tolerance to contact allergens. (2003) (54)
- Factors linked to disease severity and time to remission in patients with chronic spontaneous urticaria (2017) (54)
- Abschied vom rationalen Wähler : warum Wahlen im Fernsehen entschieden werden (2005) (54)
- German version of ItchyQoL: validation and initial clinical findings. (2013) (54)
- Prevalence and clinical characteristics of chronic spontaneous urticaria in pediatric patients (2018) (54)
- ATTENTUS, a German online survey of patients with chronic urticaria highlighting the burden of disease, unmet needs and real‐life clinical practice (2016) (53)
- Inflammatory murine skin responses to UV-B light are partially dependent on endothelin-1 and mast cells. (2006) (53)
- Fasciola hepatica Tegumental Coat Impairs Mast Cells’ Ability To Drive Th1 Immune Responses (2013) (53)
- Clinical management of urticaria using omalizumab: the first licensed biological therapy available for chronic spontaneous urticaria (2016) (53)
- ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria (2015) (52)
- How to Approach Chronic Inducible Urticaria. (2018) (52)
- The status quo and quo vadis of mast cells (2005) (52)
- Regulation of type 2 immunity to helminths by mast cells (2012) (52)
- Antihistamine‐resistant urticaria factitia successfully treated with anti‐immunoglobulin E therapy (2010) (52)
- Treatment strategies in mastocytosis. (2014) (52)
- Transfer of regulatory T cells into abortion-prone mice promotes the expansion of uterine mast cells and normalizes early pregnancy angiogenesis (2015) (52)
- Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: a randomized, double-blind, placebo-controlled phase 3 trial. (2020) (51)
- Butyrate inhibits human mast cell activation via epigenetic regulation of FcεRI‐mediated signaling (2020) (51)
- Triggers and Prodromal Symptoms of Angioedema Attacks in Patients With Hereditary Angioedema. (2016) (50)
- Efficacy and safety of canakinumab in urticarial vasculitis: an open-label study. (2013) (50)
- Analysis of disease activity categories in chronic spontaneous/idiopathic urticaria (2017) (49)
- Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) (2016) (49)
- Hereditary Angioedema Caused By C1-Esterase Inhibitor Deficiency: A Literature-Based Analysis and Clinical Commentary on Prophylaxis Treatment Strategies (2011) (49)
- Non‐pathogenic commensal Escherichia coli bacteria can inhibit degranulation of mast cells (2008) (48)
- Omalizumab rapidly improves angioedema‐related quality of life in adult patients with chronic spontaneous urticaria: X‐ACT study data (2017) (48)
- Turkish version of the chronic urticaria quality of life questionnaire: cultural adaptation, assessment of reliability and validity. (2012) (48)
- S2k‐Leitlinie – Chronischer Pruritus (2012) (48)
- Critical temperature threshold measurement for cold urticaria: a randomized controlled trial of H1‐antihistamine dose escalation (2012) (47)
- Role and Relevance of Mast Cells in Fungal Infections (2012) (47)
- Benefit of mepolizumab treatment in a patient with chronic spontaneous urticaria (2018) (47)
- Mast cells protect from post-traumatic spinal cord damage in mice by degrading inflammation-associated cytokines via mouse mast cell protease 4 (2014) (47)
- Development of a standardized pulse-controlled ergometry test for diagnosing and investigating cholinergic urticaria. (2014) (47)
- Increased IgE levels are linked to faster relapse in patients with omalizumab-discontinued chronic spontaneous urticaria. (2017) (46)
- The ingenious mast cell: Contemporary insights into mast cell behavior and function (2020) (46)
- Open‐label, multicenter study of self‐administered icatibant for attacks of hereditary angioedema (2014) (46)
- Impact of psoriasis severity on family income and quality of life (2015) (46)
- Treatment of urticarial vasculitis: A systematic review (2019) (46)
- PLUSH TACSY: Homonuclear planar TACSY with two-band selective shaped pulses applied to Cα,C′ transfer and Cβ,Caromatic correlations (1996) (46)
- How to treat patients with chronic spontaneous urticaria with omalizumab: Questions and answers. (2019) (45)
- Can on-demand non-sedating antihistamines improve urticaria symptoms? A double-blind, randomized, single-dose study. (2013) (45)
- Comparison and interpretability of the available urticaria activity scores (2018) (45)
- Looking forward to new targeted treatments for chronic spontaneous urticaria (2017) (44)
- Characterization of prodromal symptoms in a large population of patients with hereditary angio‐oedema (2014) (44)
- Mast Cells Limit the Exacerbation of Chronic Allergic Contact Dermatitis in Response to Repeated Allergen Exposure (2016) (44)
- Management of pediatric chronic spontaneous and physical urticaria patients with omalizumab: case series (2015) (44)
- Mas-related G protein-coupled receptor X2 and its activators in dermatologic allergies. (2020) (44)
- Innate immunity in atopic dermatitis. (2011) (43)
- Benefit from reslizumab treatment in a patient with chronic spontaneous urticaria and cold urticaria (2018) (43)
- Comparison of Urticaria Activity Score Over 7 Days (UAS7) Values Obtained from Once-Daily and Twice-Daily Versions: Results from the ASSURE-CSU Study (2018) (43)
- Disease Severity, Activity, Impact, and Control and How to Assess Them in Patients with Hereditary Angioedema (2017) (43)
- F12‐46C/T polymorphism as modifier of the clinical phenotype of hereditary angioedema (2015) (42)
- Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies (2020) (42)
- Symptomatic dermographism: an inadequately described disease (2015) (42)
- H1-Antihistamine Up-Dosing in Chronic Spontaneous Urticaria: Patients' Perspective of Effectiveness and Side Effects – A Retrospective Survey Study (2011) (42)
- Rupatadine improves quality of life in mastocytosis: a randomized, double‐blind, placebo‐controlled trial (2013) (42)
- Masse statt Klasse? Einige kritische Anmerkungen zu Repräsentativität und Validität von Online-Befragungen (2009) (41)
- Positive impact of omalizumab on angioedema and quality of life in patients with refractory chronic idiopathic/spontaneous urticaria: analyses according to the presence or absence of angioedema (2017) (41)
- Mast cells are critical for controlling the bacterial burden and the healing of infected wounds (2019) (41)
- Long‐term prophylaxis of hereditary angioedema with androgen derivates: a critical appraisal and potential alternatives (2011) (40)
- Acquired cold urticaria symptoms can be safely prevented by ebastine (2007) (40)
- Repeat treatment with icatibant for multiple hereditary angioedema attacks: FAST‐2 open‐label study (2013) (40)
- Predictors of treatment response in chronic spontaneous urticaria (2021) (40)
- The role of eosinophils in chronic spontaneous urticaria. (2020) (40)
- Positive CD63 Basophil Activation Tests Are Common in Children with Chronic Spontaneous Urticaria and Linked to High Disease Activity (2016) (40)
- Antihistamine‐resistant chronic spontaneous urticaria: 1‐year data from the AWARE study (2018) (40)
- Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: an expert opinion (2017) (40)
- Modern Approaches to the Diagnosis and Treatment of Cold Contact Urticaria (2010) (39)
- Chronic idiopathic urticaria (CIU) is no longer idiopathic: time for an update (2013) (39)
- Adaptation and initial results of the Polish version of the GA(2)LEN chronic urticaria quality of life questionnaire (CU-Q(2)oL). (2011) (39)
- Biologics for the Use in Chronic Spontaneous Urticaria: When and Which. (2021) (38)
- Histamine and antihistamines in atopic dermatitis. (2010) (38)
- Total IgE as a Marker for Chronic Spontaneous Urticaria (2021) (38)
- Antihistamine updosing reduces disease activity in patients with difficult-to-treat cholinergic urticaria. (2016) (38)
- Rupatadine 20 mg and 40 mg are Effective in Reducing the Symptoms of Chronic Cold Urticaria. (2016) (37)
- Successful omalizumab treatment in chronic spontaneous urticaria is associated with lowering of serum IL‐31 levels (2016) (36)
- Matrix metalloproteinase‐9: a novel biomarker for monitoring disease activity in patients with chronic urticaria patients? (2009) (36)
- Cold urticaria – What we know and what we do not know (2020) (36)
- Role of Substance P and Its Receptor Neurokinin 1 in Chronic Prurigo: A Randomized, Proof-of-Concept, Controlled Trial with Topical Aprepitant. (2018) (36)
- Chronic urticaria: tools to aid the diagnosis and assessment of disease status in daily practice (2015) (36)
- IgM and IgA in addition to IgG autoantibodies against FcɛRIα are frequent and associated with disease markers of chronic spontaneous urticaria (2020) (35)
- The global impact of the COVID‐19 pandemic on the management and course of chronic urticaria (2020) (35)
- Development and validation of the mastocytosis quality of life questionnaire: MC‐QoL (2016) (35)
- Immature mast cells exhibit rolling and adhesion to endothelial cells and subsequent diapedesis triggered by E‐ and P‐selectin, VCAM‐1 and PECAM‐1 (2010) (35)
- T cell killing by tolerogenic dendritic cells protects mice from allergy. (2011) (35)
- Intact hair follicle innervation is not essential for anagen induction and development (1998) (35)
- Neurotrophin‐3 regulates mast cell functions in neonatal mouse skin (2004) (35)
- Basophilic histamine content and release during venom immunotherapy: Insights by flow cytometry (2013) (34)
- ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice (2020) (34)
- Differences in chronic spontaneous urticaria between Europe and Central/South America: results of the multi-center real world AWARE study (2018) (34)
- Disease Activity Only Moderately Correlates with Quality of Life Impairment in Patients with Chronic Spontaneous Urticaria (2013) (34)
- [Antipruritic efficacy of a high-dosage antihistamine therapy. Results of a retrospectively analysed case series]. (2009) (34)
- Anaphylaxis caused by mosquito allergy in systemic mastocytosis (2013) (34)
- Rupatadine is effective in the treatment of chronic spontaneous urticaria in children aged 2–11 years (2016) (33)
- Hereditary Angioedema with Normal C1 Inhibitor: Update on Evaluation and Treatment. (2017) (33)
- Treatment of HAE Attacks in the Icatibant Outcome Survey: An Analysis of Icatibant Self-Administration versus Administration by Health Care Professionals (2015) (33)
- Desloratadine inhibits human skin mast cell activation and histamine release. (2009) (33)
- Patients with chronic urticaria exhibit increased rates of sensitisation to Candida albicans, but not to common moulds (2009) (33)
- Interleukin-33 promotes the proliferation of mouse mast cells through ST2/MyD88 and p38 MAPK-dependent and Kit-independent pathways. (2014) (33)
- Mast cells in endometriosis: guilty or innocent bystanders? (2012) (33)
- NMR solution structure and dynamics of the peptidyl-prolyl cis-trans isomerase domain of the trigger factor from Mycoplasma genitalium compared to FK506-binding protein. (2002) (33)
- Selected urticaria patients benefit from a referral to tertiary care centres – results of an expert survey (2013) (32)
- Omalizumab substantially improves dermatology‐related quality of life in patients with chronic spontaneous urticaria (2017) (32)
- European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives (2012) (32)
- Systematic review of treatments for chronic spontaneous urticaria with inadequate response to licensed first‐line treatments (2015) (32)
- H1‐antihistamines and urticaria: how can we predict the best drug for our patient? (2012) (32)
- Calcitonin gene‐related peptide and vascular endothelial growth factor are expressed in lesional but not uninvolved skin in chronic spontaneous urticaria (2014) (32)
- What determines the success or failure of intracellular cutaneous parasites? Lessons learned from leishmaniasis (2009) (32)
- Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria: A systematic review for the EAACI Biologicals Guidelines (2020) (32)
- The majority of brain mast cells in B10.PL mice is present in the hippocampal formation (2006) (31)
- Skin and Systemic Inflammation in Schnitzler's Syndrome Are Associated With Neutrophil Extracellular Trap Formation (2019) (31)
- Development of the Angioedema Control Test—A patient‐reported outcome measure that assesses disease control in patients with recurrent angioedema (2019) (31)
- Interleukin‐17 is a potential player and treatment target in severe chronic spontaneous urticaria (2020) (31)
- Histamine intolerance in patients with chronic spontaneous urticaria (2016) (31)
- Understanding human mast cells: lesson from therapies for allergic and non-allergic diseases (2021) (31)
- Hereditary angioedema: an update on available therapeutic options (2010) (31)
- Polidocanol inhibits cowhage ‐ but not histamine‐induced itch in humans (2014) (30)
- Antipruritische Wirksamkeit einer hoch dosierten Antihistaminikatherapie (2009) (30)
- Effects of omalizumab in a patient with three types of chronic urticaria (2014) (30)
- A novel method to generate and culture human mast cells: Peripheral CD34+ stem cell-derived mast cells (PSCMCs). (2014) (30)
- Unexplained recurrent fever: when is autoinflammation the explanation? (2013) (30)
- Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: The OPuS‐2 study (2018) (30)
- Murine and human mast cell progenitors. (2016) (29)
- Intractable Headaches, Ischemic Stroke, and Seizures Are Linked to the Presence of Anti-β2GPI Antibodies in Patients with Systemic Lupus Erythematosus (2015) (29)
- Validation of the Angioedema Control Test (AECT) - a patient reported outcome instrument for assessing angioedema control. (2020) (29)
- Atopic predisposition in cholinergic urticaria patients and its implications (2016) (29)
- Platelet‐activating factor (PAF) induces wheal and flare skin reactions independent of mast cell degranulation (2013) (29)
- A role for Bax in the regulation of apoptosis in mouse mast cells. (2000) (29)
- Ubiquitin Backbone Motion Studied via NHN−C‘Cα Dipolar−Dipolar and C‘−C‘Cα/NHN CSA−Dipolar Cross-Correlated Relaxation (2000) (29)
- Mast cells determine the magnitude of bacterial toxin‐induced skin inflammation (2009) (29)
- Cost‐intensive, time‐consuming, problematical? How physicians in private practice experience the care of urticaria patients (2012) (29)
- Miltefosine inhibits human mast cell activation and mediator release both in vitro and in vivo. (2009) (29)
- Targeted next-generation sequencing for the molecular diagnosis of hereditary angioedema due to C1-inhibitor deficiency. (2018) (29)
- A novel, simple, validated and reproducible instrument for assessing provocation threshold levels in patients with symptomatic dermographism (2013) (29)
- Mast cells protect from skin tumor development and limit tumor growth during cutaneous de novo carcinogenesis in a Kit‐dependent mouse model (2014) (28)
- In psoriasis, levels of hope and quality of life are linked (2014) (28)
- An Open-Label, Proof-of-Concept Study of Lirentelimab for Antihistamine-Resistant Chronic Spontaneous and Inducible Urticaria. (2021) (28)
- MRGPRX2 and Immediate Drug Hypersensitivity: Insights from Cultured Human Mast Cells. (2020) (28)
- Reliabilität und Validität von RTR-Messungen (2005) (28)
- Clinical Measures of Chronic Urticaria. (2017) (28)
- Brain histamine H1 receptor occupancy measured by PET after oral administration of levocetirizine, a non-sedating antihistamine (2015) (28)
- Urticaria: its history-based diagnosis and etiologically oriented treatment. (2008) (28)
- Cardiac safety of second‐generation H1‐antihistamines when updosed in chronic spontaneous urticaria (2019) (28)
- Omalizumab normalizes the gene expression signature of lesional skin in patients with chronic spontaneous urticaria: A randomized, double‐blind, placebo‐controlled study (2018) (27)
- Hair growth‐modulation by adrenergic drugs (1999) (27)
- Development and validation of the Cholinergic Urticaria Quality‐of‐Life Questionnaire (CholU‐QoL) (2018) (27)
- Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic (2020) (27)
- A new instrument for the assessment of patient‐defined benefit in the treatment of allergic rhinitis (2011) (27)
- Clinically relevant outcome measures for assessing disease activity, disease control and quality of life impairment in patients with chronic spontaneous urticaria and recurrent angioedema (2015) (27)
- Update on chronic urticaria: focusing on mechanisms (2008) (26)
- Fenebrutinib in H1 antihistamine-refractory chronic spontaneous urticaria: a randomized phase 2 trial (2021) (26)
- Effect of Dietary Fiber and Metabolites on Mast Cell Activation and Mast Cell-Associated Diseases (2018) (26)
- Health-related quality of life with hereditary angioedema following prophylaxis with subcutaneous C1-inhibitor with recombinant hyaluronidase. (2017) (26)
- Hereditäres Angioödem durch C1-Inhibitor-Mangel (2012) (26)
- Activation of the Prostaglandin E2 receptor EP2 prevents house dust mite‐induced airway hyperresponsiveness and inflammation by restraining mast cells’ activity (2015) (26)
- URTICARIA AND ANGIOEDEMA ACROSS THE AGES. (2020) (26)
- Wie Journalisten mit Ungewissheit umgehen. Eine Untersuchung am Beispiel der Berichterstattung u?ber die Folgen des Klimawandels (2011) (26)
- Prevention of signs and symptoms of dermographic urticaria by single‐dose ebastine 20 mg (2009) (26)
- Prophylaxis of hereditary angioedema attacks: A randomized trial of oral plasma kallikrein inhibition with avoralstat. (2016) (25)
- [Chronic urticaria. Prevalence, course, prognostic factors and impact]. (2010) (25)
- Chronic spontaneous urticaria: how to assess quality of life in patients receiving treatment. (2011) (25)
- Chronic spontaneous urticaria – a management pathway for patients with chronic spontaneous urticaria (2015) (25)
- Dupilumab in Treatment of Chronic Prurigo: a Case Series and Literature Review. (2019) (25)
- Real-life treatment of cholinergic urticaria with omalizumab. (2019) (25)
- Chronische Urtikaria (2010) (24)
- Safeguarding of Fetal Growth by Mast Cells and Natural Killer Cells: Deficiency of One Is Counterbalanced by the Other (2017) (24)
- Treatments of cold urticaria: A systematic review (2019) (24)
- In chronic spontaneous urticaria, IgE against staphylococcal enterotoxins is common and functional (2018) (24)
- Pruritus and sleep disturbances in patients with psoriasis (2019) (24)
- Clinical features and epidemiology of cutaneous leishmaniasis and Leishmania major/HIV co-infection in Cameroon: results of a large cross-sectional study. (2012) (24)
- Rupatadine for the treatment of allergic rhinitis and urticaria (2011) (24)
- Histamine, TNF, C5a, IL-6, -9, -18, -31, -33, TSLP, neopterin, and VEGF are not elevated in chronic spontaneous urticaria. (2013) (24)
- Effects of topical treatment with the raft modulator miltefosine and clobetasol in cutaneous mastocytosis: a randomized, double‐blind, placebo‐controlled trial (2010) (24)
- Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey (2017) (24)
- Efficacy and safety of dupilumab for moderate‐to‐severe atopic dermatitis: A systematic review for the EAACI biologicals guidelines (2020) (24)
- Autoimmune Diseases Are Linked to Type IIb Autoimmune Chronic Spontaneous Urticaria (2021) (24)
- Management of chronic spontaneous urticaria: a worldwide perspective (2018) (24)
- Cold Urticaria Patients Exhibit Normal Skin Levels of Functional Mast Cells and Histamine after Tolerance Induction (2012) (24)
- Development and content validity testing of a patient-reported outcomes questionnaire for the assessment of hereditary angioedema in observational studies (2015) (23)
- Human Mast Cell Tryptase Is a Potential Treatment for Snakebite Envenoming Across Multiple Snake Species (2018) (23)
- Antihistamine‐resistant chronic spontaneous urticaria remains undertreated: 2‐year data from the AWARE study (2020) (23)
- Does allergy impair innate immunity? Leads and lessons from atopic dermatitis (2010) (23)
- Hair growth control by immunosuppression (1996) (23)
- Long-term Efficacy of Canakinumab in the Treatment of Schnitzler Syndrome. (2020) (23)
- Immunological effects and potential mechanisms of action of autologous serum therapy in chronic spontaneous urticaria (2019) (23)
- Questions and answers in chronic urticaria: where do we stand and where do we go? (2016) (23)
- Genetic Determinants of C1 Inhibitor Deficiency Angioedema Age of Onset (2017) (23)
- Guideline: Hereditary angioedema due to C1 inhibitor deficiency (2019) (23)
- The characteristics and impact of pruritus in adult dermatologic patients: A prospective, cross-sectional study. (2020) (23)
- Randomized, double‐blind, placebo‐controlled study of safety and efficacy of miltefosine in antihistamine‐resistant chronic spontaneous urticaria (2013) (23)
- Angioedema in the omalizumab chronic idiopathic/spontaneous urticaria pivotal studies. (2016) (22)
- Successful treatment of an acute attack of acquired angioedema with the bradykinin‐B2‐receptor antagonist icatibant (2011) (22)
- Chronic urticaria can be caused by cancer and resolves with its cure (2018) (22)
- Long‐term reduction in local inflammation by a lipid raft molecule in atopic dermatitis (2010) (22)
- Safety and Efficacy of Desloratadine in Subjects with Seasonal Allergic Rhinitis or Chronic Urticaria (2010) (22)
- Diagnosis and treatment of chronic inducible urticaria (2019) (21)
- Allergen immunotherapy in the current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI and GPA (2020) (21)
- Validity, reliability and interpretability of the Thai version of the urticaria control test (UCT) (2016) (21)
- Wissensvermittlung in der Mediendemokratie. Wie Medien und politische Akteure die Inhalte von Wahlprogrammen kommunizieren (2009) (21)
- Improvement in diagnostic delays over time in patients with hereditary angioedema: findings from the Icatibant Outcome Survey (2018) (21)
- Effects of Antihistamines on Innate Immune Responses to Severe Bacterial Infection in Mice (2011) (21)
- Skin microdialysis: methods, applications and future opportunities—an EAACI position paper (2019) (21)
- Treatment of notalgia paraesthetica with an 8% capsaicin patch (2011) (21)
- Comorbidity of viral hepatitis and chronic spontaneous urticaria: A systematic review (2018) (21)
- Updosing of bilastine is effective in moderate to severe chronic spontaneous urticaria: A real‐life study (2018) (21)
- Benefit of benralizumab treatment in a patient with chronic symptomatic dermographism (2019) (20)
- Patients with chronic cold urticaria may benefit from doxycycline therapy (2017) (20)
- Das Paradox der Medienwirkungsforschung (2004) (20)
- Use of skin biomarker profiles to distinguish Schnitzler syndrome from chronic spontaneous urticaria: results of a pilot study (2018) (20)
- Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks (2020) (20)
- Ultraviolet radiation and skin mast cells: Effects, mechanisms and relevance for skin diseases (2018) (20)
- Definition, aims, and implementation of GA2LEN/HAEi Angioedema Centers of Reference and Excellence (2020) (20)
- Auf den Spuren der Lügenpresse (2019) (20)
- Inflammatory skin responses induced by icatibant injection are mast cell mediated and attenuated by H1‐antihistamines (2012) (20)
- The status quo and unmet needs in the management of allergic rhinitis and chronic rhinosinusitis: a Malaysian perspective (2014) (20)
- On the Lipophilic Nature of Autoreactive IgE in Chronic Spontaneous Urticaria (2019) (20)
- Cold-induced urticarial autoinflammatory syndrome related to factor XII activation (2020) (19)
- Chronic urticaria – What does the new guideline tell us? (2018) (19)
- Cardioprotective C-kit+ Bone Marrow Cells Attenuate Apoptosis after Acute Myocardial Infarction in Mice - In-vivo Assessment with Fluorescence Molecular Imaging (2013) (19)
- The inhibition by levocetirizine and fexofenadine of the histamine-induced wheal and flare response in healthy Caucasian and Japanese volunteers. (2013) (19)
- The Henna pigment Lawsone activates the Aryl Hydrocarbon Receptor and impacts skin homeostasis (2019) (19)
- Omalizumab for the treatment of chronic urticaria (2015) (19)
- Cholinergic urticaria patients of different age groups have distinct features (2017) (19)
- Analysis of characteristics associated with reinjection of icatibant: Results from the icatibant outcome survey. (2015) (19)
- Consensus on treatment goals in hereditary angioedema: a global Delphi initiative. (2021) (18)
- Autoreaktive Urtikaria und Autoimmunurtikaria (2004) (18)
- Differences and Similarities in the Mechanisms and Clinical Expression of Bradykinin-Mediated vs. Mast Cell–Mediated Angioedema (2021) (18)
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases (2022) (18)
- Chronic Urticaria in Children: Still Itching for Insight. (2017) (18)
- Beyond flat weals: validation of a three‐dimensional imaging technology that will improve skin allergy research (2008) (18)
- Management of urticarial vasculitis: A worldwide physician perspective☆ (2020) (18)
- Autoimmune chronic spontaneous urticaria detection with IgG anti-TPO and total IgE. (2021) (18)
- Clinical Evaluation of Measuring the ACT during Elective Cardiac Surgery with Two Different Devices. (2018) (18)
- Impact of lanadelumab on health‐related quality of life in patients with hereditary angioedema in the HELP study (2020) (18)
- Urticarial vasculitis and Schnitzler syndrome. (2014) (18)
- Novel Insights on MRGPRX2-Mediated Hypersensitivity to Neuromuscular Blocking Agents And Fluoroquinolones (2021) (18)
- The Icatibant Outcome Survey: experience of hereditary angioedema management from six European countries (2017) (18)
- How to discontinue omalizumab in chronic spontaneous urticaria? (2019) (17)
- Mast cells drive IgE-mediated disease but may be bystanders in many other inflammatory and neoplastic conditions. (2019) (17)
- Adaptación transcultural del cuestionario Urticaria Control Test del alemán al castellano (2015) (17)
- Skin provocation tests may help to diagnose atopic dermatitis (2016) (17)
- Successful treatment of hereditary angioedema with bradykinin B2‐receptor antagonist icatibant (2009) (17)
- Antinuclear antibodies are common and linked to poor response to omalizumab treatment in patients with CSU (2020) (17)
- Treatment of hereditary angioedema with icatibant: efficacy in clinical trials versus effectiveness in the real-world setting. (2014) (17)
- Lactic acid sting test does not differentiate between facial and generalized skin functional impairment in sensitive skin in atopic dermatitis and rosacea. (2014) (17)
- [Hypocomplementemic urticarial vasculitis syndrome. Successful therapy with intravenous immunoglobulins]. (2007) (17)
- Chronic urticaria treatment patterns and changes in quality of life: AWARE study 2-year results (2020) (17)
- Sagen Bilder mehr als tausend Worte? Die Relevanz verbaler und visueller Informationen für die Urteilsbildung über Personen im Fernsehen (2009) (17)
- Diagnosis of urticaria (2013) (16)
- Validation of the Turkish version of the Urticaria Control Test: Correlation with other tools and comparison between spontaneous and inducible chronic urticaria (2019) (16)
- H1‐Antihistamines and itch in atopic dermatitis (2015) (16)
- The effects of Fasciola hepatica tegumental antigens on mast cell function. (2013) (16)
- Sexual functioning is frequently and markedly impaired in female patients with chronic spontaneous urticaria. (2019) (16)
- Long‐term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE Study (2021) (16)
- Use of topical steroids is largely restricted by irrational emotional concerns in both patients and physicians (2008) (16)
- Angioedema quality of life questionnaire (AE-QoL) - interpretability and sensitivity to change (2019) (16)
- A novel deep intronic SERPING1 variant as a cause of hereditary angioedema due to C1-inhibitor deficiency. (2020) (16)
- Mast cells cultured from IL-3-treated mice show impaired responses to bacterial antigen stimulation (2011) (16)
- Anti‐KIT monoclonal antibody CDX‐0159 induces profound and durable mast cell suppression in a healthy volunteer study (2022) (15)
- Allergen-Immuntherapie in der aktuellen Covid-19-Pandemiea, b, c (2020) (15)
- Effective control of recalcitrant pruritus by bevacizumab: a possible role for vascular endothelial growth factor in chronic itch? (2013) (15)
- In vivo non-invasive staining-free visualization of dermal mast cells in healthy, allergy and mastocytosis humans using two-photon fluorescence lifetime imaging (2020) (15)
- Omalizumab may not inhibit mast cell and basophil activation in vitro (2015) (15)
- Neues von der internationalen Leitlinie für Diagnostik und Therapie der chronischen Urtikaria (2013) (14)
- Autoimmune chronic spontaneous urticaria. (2022) (14)
- Omalizumab for chronic urticaria. (2013) (14)
- Hypokomplementämisches Urtikaria-Vaskulitis-Syndrom (2007) (14)
- Der Einfluss der Pressemitteilungen der Bundesparteien auf die Berichterstattung im Bundestagswahlkampf 2002 (2004) (14)
- Immunoregulation in cutaneous allergy: prevention and control (2012) (14)
- Membrane‐bound stem cell factor is the major but not only driver of fibroblast‐induced murine skin mast cell differentiation (2017) (14)
- Cross-Cultural Adaptation of the Urticaria Control Test From German to Castilian Spanish. (2015) (14)
- Pharmacotherapy of chronic spontaneous urticaria (2013) (14)
- Seasonal Exacerbation of Asthma Is Frequently Associated with Recurrent Episodes of Acute Urticaria (2016) (14)
- Knowledge and management of chronic spontaneous urticaria in Latin America: a cross-sectional study in Ecuador (2017) (14)
- Disease activity and stress are linked in a subpopulation of chronic spontaneous urticaria patients (2020) (14)
- Long‐term safety of icatibant treatment of patients with angioedema in real‐world clinical practice (2017) (14)
- Successful treatment of cholinergic urticaria with methantheliniumbromide (2015) (13)
- Bradykinin in health and disease: proceedings of the Bradykinin Symposium 2012, Berlin 23–24 August 2012 (2014) (13)
- Warum TV-Duelle Wahlen entscheiden können Befunde und Konsequenzen der TV-Duell-Studie 2005 (2007) (13)
- Selected recent advances in understanding the role of human mast cells in health and disease. (2022) (13)
- Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both (2021) (13)
- Spleen tyrosine kinase inhibition blocks airway constriction and protects from Th2‐induced airway inflammation and remodeling (2017) (13)
- Risk factors for systemic reactions in typical cold urticaria: Results from the COLD‐CE study (2021) (13)
- Mast cells, cortistatin, and its receptor, MRGPRX2, are linked to the pathogenesis of chronic prurigo. (2022) (13)
- Association of CCL2 with systemic inflammation in Schnitzler syndrome (2018) (13)
- An internet survey on self‐reported food allergy in Greece: clinical aspects and lack of appropriate medical consultation (2013) (13)
- Angioedema Activity Score (AAS): A Valid and Reliable Tool to Use in Asian Patients (2019) (13)
- State of care for patients with systemic autoinflammatory diseases – Results of a tertiary care survey (2019) (13)
- Rapid identification of human mast cell degranulation regulators using functional genomics coupled to high-resolution confocal microscopy (2020) (12)
- Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one‐year extension study (2021) (12)
- In chronic spontaneous urticaria, high numbers of dermal endothelial cells, but not mast cells, are linked to recurrent angio‐oedema (2018) (12)
- Delayed Pressure Urticaria: A Systematic Review of Treatment Options. (2020) (12)
- Nonverbale politische Kommunikation (2016) (12)
- Mast cells: Promotors of health and modulators of disease. (2019) (12)
- Efficacy and safety of CD24Fc in hospitalised patients with COVID-19: a randomised, double-blind, placebo-controlled, phase 3 study (2022) (12)
- Personalisierung durch Priming Die Wirkungen des TV-Duells auf die Urteilskriterien der Wähler (2007) (12)
- Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey (2017) (12)
- Fakten oder Floskeln? (2007) (12)
- In severe COVID-19, SARS-CoV-2 induces a chronic, TGF-β-dominated adaptive immune response (2020) (12)
- Epidemiology, comorbidities, and healthcare utilization of patients with chronic urticaria in Germany (2021) (12)
- Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey (2017) (12)
- Zum Mechanismus des kohärenten Wasserstofftunnelns in Trihydridokomplexen (1992) (11)
- Urticaria crónica: estudio etiológico prospectivo e importancia del síndrome autoinmune (2004) (11)
- Tanjev Schultz: Geschwätz oder Diskurs? Die Rationalität politischer Talkshows im Fernsehen. Köln: Von Halem, 2006 (2007) (11)
- Anxiety and depression seem less common in patients with autoreactive chronic spontaneous urticaria (2013) (11)
- The Chronic Urticaria Registry: rationale, methods and initial implementation (2020) (11)
- The complex role of mast cells in fungal infections (2019) (11)
- Olaparib Desensitization in a Patient with Recurrent Peritoneal Cancer. (2018) (11)
- The search for mast cell and basophil models – are we getting closer to pathophysiological relevance? (2015) (11)
- Current and future therapies for treating chronic spontaneous urticaria (2016) (11)
- Skin Mast Cells Contribute to Sporothrix schenckii Infection (2020) (11)
- What is the contribution of IgE to nasal polyposis? (2021) (11)
- Minimal important difference of the Chronic Urticaria Quality of Life Questionnaire (CU‐Q2oL) (2019) (11)
- Learnings from real-life experience of using omalizumab for chronic urticaria in Latin America (2019) (11)
- The usage, quality and relevance of information and communications technologies in patients with chronic urticaria: A UCARE study (2020) (11)
- Lanadelumab efficacy, safety, and injection interval extension in HAE - a real life study. (2021) (11)
- Evidence that the endothelin A receptor can enhance IgE-dependent anaphylaxis in mice. (2011) (11)
- A mutation in the kringle domain of human factor XII that causes autoinflammation, disturbs zymogen quiescence, and accelerates activation (2019) (11)
- Mast cells are critical for the limitation of thrombin‐induced skin inflammation (2018) (11)
- Miltefosine: a novel treatment option for mast cell-mediated diseases (2013) (11)
- Real‐life treatment of patients with cholinergic urticaria in German‐speaking countries (2019) (10)
- Galactose-α-1,3-Galactose Allergy Is Not a Hitherto Unrecognized Cause of Chronic Spontaneous Urticaria (2015) (10)
- Development and validation of the mastocytosis activity score (2018) (10)
- Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (2020) (10)
- Bruton's tyrosine kinase inhibition—An emerging therapeutic strategy in immune‐mediated dermatological conditions (2022) (10)
- EAACI Biologicals Guidelines—dupilumab for children and adults with moderate‐to‐severe atopic dermatitis (2020) (10)
- Tocilizumab treatment in patients with Schnitzler syndrome: An open-label study. (2021) (10)
- Long‐term safety and effectiveness of berotralstat for hereditary angioedema: The open‐label APeX‐S study (2021) (10)
- Lower IgA Levels in Chronic Spontaneous Urticaria Are Associated With Lower IgE Levels and Autoimmunity (2021) (10)
- Chronic urticaria in most patients is poorly controlled (2017) (10)
- Multiple Phosphorylation Sites Confer Reproducibility of the Rod's Single-Photon Responses (2006) (10)
- What we know (and don't know) about the biology and functions of mast cells and basophils (2018) (10)
- Allergen‐loaded strontium‐doped hydroxyapatite spheres improve allergen‐specific immunotherapy in mice (2016) (10)
- Treatment strategies in urticaria (2010) (10)
- The diagnostic workup in chronic spontaneous urticaria - what to test and why. (2021) (10)
- Angioedema frequently occurs in cholinergic urticaria. (2019) (9)
- Alterations in Hair Follicle Morphology and Hair Shaft Production After Follicular Unit Transplantation (2016) (9)
- Subcutaneous administration of human C1 inhibitor with recombinant human hyaluronidase in patients with hereditary angioedema. (2016) (9)
- First detection of Leishmania donovani in sand flies from Cameroon and its epidemiological implications (2018) (9)
- Expert consensus on practical aspects in the treatment of chronic urticaria (2021) (9)
- Alternative treatments for chronic spontaneous urticaria beyond the guideline algorithm (2017) (9)
- What are the most promising strategies for the therapeutic immunomodulation of allergic diseases? Note (2001) (9)
- Dupilumab Significantly Reduces Itch and Hives in Patients With Chronic Spontaneous Urticaria: Results From a Phase 3 Trial (LIBERTY-CSU CUPID Study A) (2022) (9)
- A simulated car‐driving study on the effects of acute administration of levocetirizine, fexofenadine, and diphenhydramine in healthy Japanese volunteers (2016) (9)
- Skin Site Mast Cell Numbers Correlate with Rates of Nodular Growth, but Not Incidence, of Basal Cell Carcinoma (2005) (9)
- Hair cycle-associated changes in splenocyte proliferation. (1997) (9)
- Elderly versus younger patients with hereditary angioedema type I/II: patient characteristics and safety analysis from the Icatibant Outcome Survey (2019) (9)
- Association between depth of response and overall survival: Exploratory analysis in patients with previously untreated advanced renal cell carcinoma (aRCC) in CheckMate 214 (2019) (9)
- Rupatadine in Established Treatment Schemes Improves Chronic Spontaneous Urticaria Symptoms and Patients’ Quality of Life: a Prospective, Non-interventional Trial (2015) (9)
- Peripheral blood cultured mast cells: Phenotypic and functional outcomes of different culture protocols. (2021) (9)
- Populistisch und unkonkret Die unmittelbare Wahrnehmung des TV-Duells (2007) (9)
- Warum die Macht der Fernsehbilder wächst (2003) (9)
- P152 CLINICAL ACTIVITY OF AK002, AN ANTI-SIGLEC-8 ANTIBODY, IN MULTIPLE FORMS OF UNCONTROLLED CHRONIC URTICARIA (2019) (8)
- A novel histopathological scoring system to distinguish urticarial vasculitis from chronic spontaneous urticaria (2021) (8)
- Uncontrolled allergic rhinitis during treatment and its impact on quality of life: A cluster randomized trial (2016) (8)
- Coexistence of Angioedema Alone with Impaired Glucose Tolerance (2015) (8)
- Can Internet surveys help us understanding allergic disorders? – results from a large survey in urticaria in Greece (2011) (8)
- [Childhood-onset mastocytosis]. (2012) (8)
- adaptation and validation of the israeli version of the chronic urticaria quality of life questionnaire ( cu-q 2 ol ) (2008) (8)
- Remibrutinib, a novel BTK inhibitor, demonstrates promising efficacy and safety in chronic spontaneous urticaria. (2022) (8)
- Evaluation of the Immunogenicity of the Synthetic α-Melanocyte-Stimulating Hormone (α-MSH) Analogue Afamelanotide ([Nle4-D-Phe7]-α-MSH, Scenesse®) in Erythropoietic Protoporphyria Patients by ELISA Detecting Both Anti-Afamelanotide and Anti-α-MSH Antibodies (2014) (8)
- Mastozytose@@@Mastocytosis: Leitlinie der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI) und der Deutschen Dermatologischen Gesellschaft (DDG) (2009) (8)
- Markers for the involvement of endothelial cells and the coagulation system in chronic urticaria: A systematic review (2021) (8)
- Treatment of Severely Recalcitrant Chronic Spontaneous Urticaria: A Discussion of Relevant Issues (2015) (8)
- Teil 1: Klassifikation und Diagnostik der Urtikaria - deutschsprachige Version der internationalen S3-Leitlinie* (2011) (8)
- Topical inflammasome inhibition with disulfiram prevents irritant contact dermatitis (2021) (8)
- Das fragmentierte Selbst (2008) (8)
- [Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI-AeDA-GPA-DGAKI Position Paper (Pocket-Guide)]. (2020) (8)
- Healthcare Resource Utilisation Among Chronic Spontaneous/Idiopathic Urticaria Patients- Findings From The First International Burden of Illness Study (Assure-Csu). (2015) (8)
- Subcutaneous self‐injections of C1 inhibitor: an effective and safe treatment in a patient with hereditary angio‐oedema (2016) (8)
- Abstracts from the 10th C1-inhibitor deficiency workshop (2017) (8)
- What Basophil Testing Tells Us About CSU Patients – Results of the CORSA Study (2021) (8)
- Prevalence of nonspecific cutaneous vascular lesions and association with antiphospholipid antibodies in patients with systemic lupus erythematosus (2013) (8)
- Hereditary Angioedema due to C1 Inhibitor Deficiency (2019) (7)
- In psoriasis, levels of hope and quality of life are linked (2014) (7)
- T helper 22 cells from Han Chinese patients with atopic dermatitis exhibit high expression of inducible T‐cell costimulator (2020) (7)
- Chronische Urtikaria – Was bringt die neue Leitlinie? (2018) (7)
- Cross-Cultural Adaptation of the Urticaria Control Test From German to Castilian Spanish (2015) (7)
- The response to treatment in chronic spontaneous urticaria depends on how it is measured. (2019) (7)
- Schröder gegen Merkel. Wahrnehmung und Wirkung des TV-Duells (2007) (7)
- The Icatibant Outcome Survey: treatment of laryngeal angioedema attacks (2015) (7)
- EAACI/GA2LEN/EDF/WAO-Leitlinie für die Definition, Klassifikation, Diagnose und das Management der Urtikaria — konsentierte, deutschsprachige Übersetzung (2018) (7)
- Erfolgreiche Behandlung des hereditären Angioödems mit dem Bradykinin‐B2‐Rezeptor‐Antagonisten Icatibant (2010) (7)
- Mast Cells Modulate Antigen-Specific CD8+ T Cell Activation During LCMV Infection (2021) (7)
- How to control recurrent angioedema using monoclonal antibody therapies? (2019) (7)
- Mastozytosen im Kindesalter (2012) (7)
- Urticaria (2022) (7)
- Evidence for non-allergic mast cell activation in pollen-associated inflammation. (2011) (7)
- Work Productivity and Activity Impairment Among Chronic Spontaneous/Idiopathic Urticaria Patients: ResultsFrom The First International Burden of Illness Study (Assure-Csu). (2015) (7)
- Management of patients with hereditary angioedema in Germany: comparison with other countries in the Icatibant Outcome Survey (2018) (7)
- Cell-Induced Immune Suppression Mast Cells That Are Essential for Regulatory T IL-9 Production by Regulatory T Cells Recruits (2011) (7)
- [Relevance of food allergies and intolerance reactions as causes of urticaria]. (2003) (7)
- Comparison of pruritus and sensory qualities induced by capsaicin, histamine and cowhage (2019) (7)
- Validity and responsiveness of the Urticaria Activity and Impact Measure: A new patient-reported tool. (2018) (7)
- Effects of pregnancy on chronic urticaria: Results of the PREG‐CU UCARE study (2021) (7)
- Atopic dermatitis and allergic rhinitis – do co‐effects in therapy exist? (2012) (7)
- [Diagnostics and exclusion of hereditary angioedema : a standarized approach for the practice]. (2012) (7)
- Themen, Argumente, rhetorische Strategien Die Inhalte des TV-Duells (2007) (7)
- Adaptation and Validation of the Israeli Version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL). (2016) (7)
- Serum neuron specific enolase – a novel indicator for neuropsychiatric systemic lupus erythematosus? (2015) (7)
- Omalizumab in chronic inducible urticaria: A real‐life study of efficacy, safety, predictors of treatment outcome and time to response (2021) (7)
- Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food—A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper (2021) (7)
- [Diagnosis and therapy of chronic urticaria-what is expected from the revision and update of the international guidelines? A report of the public consensus conference "URTICARIA 2012"]. (2013) (7)
- G3 – Hereditäres Angioödem durch C1-Inhibitor-Mangel1 (2015) (7)
- Cold Agglutinins and Cryoglobulins Associate With Clinical and Laboratory Parameters of Cold Urticaria (2021) (6)
- Chymase-Cre; Mcl-1fl/fl Mice Exhibit Reduced Numbers of Mucosal Mast Cells (2019) (6)
- Increased angiogenesis and VEGF expression correlates with disease severity in prurigo patients (2016) (6)
- Mitigating Disparity in Health-care Resources Between Countries for Management of Hereditary Angioedema (2021) (6)
- Lack of significant skin inflammation during elimination by apoptosis of large numbers of mouse cutaneous mast cells after cessation of treatment with stem cell factor (2004) (6)
- (R)Evolution der Politikberichterstattung im Medienwandel? Die Inhalte von nachrichtenjournalistischen Online- und Offline-Angeboten im Vergleich (2014) (6)
- Urticaria and angioedema. (2014) (6)
- Leichtgläubig und manipulierbar? Die Rezeption persuasiver Wahlkampfbotschaften durch politisch Interessierte und Desinteressierte (2010) (6)
- The Classification, Pathogenesis, Diagnostic Workup, and Management of Urticaria: An Update. (2021) (6)
- EAACI Biologicals Guidelines—Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12–17 years old (2021) (6)
- The male beard hair and facial skin – challenges for shaving (2016) (6)
- Letter to the Editor: Assignment of the 1H, 13C and 15N resonances of the PPIase domain of the trigger factor from Mycoplasma genitalium (2001) (6)
- Anaphylaxis to Mepolizumab and Omalizumab in a Single Patient: Is Polysorbate the Culprit? (2020) (6)
- The Scope of Pharmacological and Clinical Effects of Modern Antihistamines, With a Special Focus on Rupatadine: Proceedings from a Satellite Symposium held at the 21st World Allergy Congress, Buenos Aires, December 8, 2009 (2010) (6)
- Relevanz von Nahrungsmittelallergien und -intoleranzreaktionen als Ursachen von Urtikaria (2003) (6)
- Symptomatic Dermographism: A Systematic Review of Treatment Options. (2020) (6)
- S3‐Leitlinie Urtikaria. Teil 2: Therapie der Urtikaria – deutschsprachige Adaption der internationalen S3‐Leitlinie (2012) (6)
- C1 Inhibitor for Routine Prophylaxis in Patients with Hereditary Angioedema: Interim Results from a European Registry Study (2016) (6)
- Effects of a topical treatment with spleen tyrosine kinase inhibitor in healthy subjects and patients with cold urticaria or chronic spontaneous urticaria: Results of a phase 1a/b randomised double‐blind placebo‐controlled study (2021) (6)
- Prevalence and factors associated with sleep disturbance in adult patients with psoriasis (2022) (6)
- Use of biologics in chronic spontaneous urticaria – beyond omalizumab therapy? (2021) (6)
- The Scope of Pharmacological and Clinical Effects of Modern Antihistamines, With a Special Focus on Rupatadine (2010) (6)
- Response of omalizumab in normocomplementemic urticarial vasculitis. (2020) (6)
- Vibratory Angioedema Subgroups, Features and Treatment: Results of a Systematic Review. (2020) (6)
- Very rarely chronic urticaria can be caused by cancer and if so, resolves with its cure (2018) (6)
- Inventory and taxonomy of phlebotomine sand flies of the Mokolo leishmaniasis focus, northern Cameroon, with description of new Sergentomyia taxa (Diptera: Psychodidae). (2019) (6)
- Sensitization against skin resident fungi is associated with atopy in cholinergic urticaria patients (2020) (6)
- Efficacy Correlates with Plasma Levels in Opus-1, a Proof-of-Concept Study of Oral Kallikrein Inhibitor BCX4161 As a Prophylaxis Against Attacks of Hereditary Angioedema (HAE) (2015) (5)
- Long-term treatment with ligelizumab achieves prolonged symptom control during the post-treatment follow-up (2020) (5)
- Effective treatment with mepolizumab in a patient with refractory Wells syndrome (2020) (5)
- Innovative approaches to avoid electric shaving‐induced skin irritation (2016) (5)
- The Anti-KIT Antibody, CDX-0159, Reduces Mast Cell Numbers and Circulating Tryptase and Improves Disease Control in Patients with Chronic Inducible Urticaria (Cindu) (2022) (5)
- Ligelizumab improves sleep interference and disease burden in patients with chronic spontaneous urticaria (2022) (5)
- Improved adalimumab dose decision with comprehensive diagnostics data. (2018) (5)
- How are patients with chronic urticaria interested in using information and communication technologies to guide their healthcare? A UCARE study (2021) (5)
- Omalizumab in chronic inducible urticaria: a real-life study of efficacy, safety, predictors of treatment outcome and time to response (2020) (5)
- Efficacy of Lanadelumab in Hereditary Angioedema Patients Switching From C1 Inhibitor Long‐Term Prophylaxis: Interim Results From the HELP Open‐Label Extension Study: 112 (2019) (5)
- OR034 Lanadelumab for prevention of attacks in hereditary angioedema: results from the phase 3 HELP study (2017) (5)
- Case Report: Omalizumab for Chronic Spontaneous Urticaria in Pregnancy (2021) (5)
- The Scope of Pharmacological and Clinical Effects of Modern Antihistamines, With a Special Focus on Rupatadine: Proceedings from a Satellite Symposium held at the 21st World Allergy Congress, Buenos Aires, December 8, 2009 (2010) (5)
- Travel‐associated infectious skin diseases (2020) (5)
- PIONEER: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Avapritinib in Patients with Indolent or Smoldering Systemic Mastocytosis (SM) With Symptoms Inadequately Controlled by Standard Therapy (2020) (5)
- Wissensvermittlung im Wahlkampf – Ursachen und Folgen politischen Wissenserwerbs im Bundestagswahlkampf 2005 (2008) (5)
- Isolation and Culture of Bone Marrow-derived Mast Cells (2014) (5)
- Klassifikation und Pathophysiologie von Angioödemen (2018) (5)
- Motivierte Zweifel. Wie die Voreinstellungen der Rezipienten zum Berichterstattungsgegenstand ihre Wahrnehmung der Medienglaubwürdigkeit beeinflussen (2018) (5)
- Omalizumab in children and adolescents with chronic urticaria: A 16‐week real‐world study (2020) (5)
- H1-antihistamine inhibition of histamine- and codeine-induced wheals does not predict response in chronic cold urticaria. (2019) (5)
- Wissenswerte Nachrichten (2014) (5)
- Real-Time Response Messung: Kontinuierliche Befragung in Echtzeit (2013) (5)
- Severe cold urticaria can point to an underlying clonal mast cell disorder (2021) (5)
- Sleep disturbance in adult dermatological patients: A cross-sectional study on prevalence, burden and associated factors. (2021) (5)
- Diagnostik und Ausschluss des hereditären Angioödems (2012) (5)
- Refined Treatment Response Criteria for Indolent Systemic Mastocytosis proposed by the ECNM-AIM Consortium. (2022) (4)
- Mastozytose: Leitlinie der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI) und der Deutschen Dermatologischen Gesellschaft (DDG) (2009) (4)
- What is urticaria? Expert opinion from the 1st Global Urticaria Forum (2015) (4)
- Addition of omalizumab to antihistamine treatment in chronic urticaria: a real-world study in China. (2020) (4)
- Pediatricians diagnosed few patients with childhood-presented hereditary angioedema: Icatibant Outcome Survey findings. (2019) (4)
- Prevalence and risk factors of chronic urticaria in China: A nationwide cross‐sectional study (2022) (4)
- Prevalence and relevance of skin autoreactivity in chronic urticaria (2009) (4)
- Characteristics and determinants of patient burden and needs in the treatment of chronic spontaneous urticaria (2020) (4)
- Kandidatenwahrnehmung in Echtzeit Anlage und Methoden der TV-Duell-Studie 2005 (2007) (4)
- Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) (2017) (4)
- Pioneer Part 2: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate Safety and Efficacy of Avapritinib in Indolent Systemic Mastocytosis (2020) (4)
- The COVID-19 Pandemic Affects Male Patients With Chronic Spontaneous Urticaria More Than Female Patients (2021) (4)
- P154 SAFETY AND TOLERABILITY OF ONCE-DAILY ORAL KALLIKREIN INHIBITOR BCX7353 IN PHASE 3 APEX-2 HAE STUDY (2019) (4)
- O10 - Rupatadine is effective and safe in the treatment of Chronic Spontaneous Urticaria (CSU) in pediatric patients (2-11 years old) (2014) (4)
- Oral Plasma Kallikrein Inhibitor BCX7353 is Safe and Effective as an On‐Demand Treatment of Angioedema Attacks in Hereditary Angioedema (HAE) Patients: Results of the ZENITH‐1 Trial: 110 (2019) (4)
- Correction: Hereditary Angioedema Attacks Resolve Faster and Are Shorter after Early Icatibant Treatment (2013) (4)
- Lanadelumab Markedly Improves Health-related Quality of Life in Hereditary Angioedema Patients in the HELP Study (2018) (4)
- Effectiveness of canakinumab treatment in Schnitzler's syndrome: a multi-center randomized placebo-controlled study (2015) (4)
- Isolation and Culture of Peritoneal Cell-derived Mast Cells (2014) (4)
- Assessment of disease activity and quality of life in patients with recurrent bradykinin-mediated versus mast cell-mediated angioedema☆ (2021) (4)
- Impaired T‐cell‐dependent protection against Leishmania major infection in HIV‐positive patients is associated with worsened disease outcome (2015) (4)
- TV-Duelle als Instrumente der Wahlkampfkommunikation: Mythen und Fakten (2007) (4)
- Vorsprung durch Technik? Die Analyse journalistischer Online-Angebote mit Hilfe automatisierter Verfahren (2015) (4)
- BCX4161, an Oral Kallikrein Inhibitor, Showed Significant Benefits on Reducing Disease Burden and Improving Quality of Life in Subjects with Hereditary Angioedema in the Opus-1 Study (2015) (4)
- Autologous serum skin test reactions in chronic spontaneous urticaria differ from heterologous cell reactions (2021) (4)
- Subcutaneous Human C1-Inhibitor with Recombinant Human Hyaluronidase for the Prevention of Angioedema Attacks in Patients with Hereditary Angioedema: Results of a Randomized, Double-Blind, Dose-Ranging, Crossover Study (2015) (4)
- In Chronic Spontaneous Urticaria, Comorbid Depression Linked to Higher Disease Activity, and Substance P Levels (2021) (4)
- Antihistamine updosing in chronic urticaria – is there enough evidence? (2016) (4)
- Der mediale Attraktivitätsbonus (2010) (4)
- A comprehensive, tri‐national, cross‐sectional analysis of characteristics and impact of pruritus in psoriasis (2022) (4)
- Antihistamines in the treatment of urticaria. (2010) (4)
- Anti-pruritic Effect of Sertaconazole 2% Cream in Atopic Dermatitis Subjects: A Prospective, Randomized, Double-blind, Vehicle-controlled, Multi-centre Clinical Trial of Efficacy, Safety and Local Tolerability. (2016) (4)
- A case of dengue fever presenting with acute urticaria. (2019) (4)
- Omalizumab is effective in patients with chronic spontaneous urticaria plus multiple chronic inducible urticaria. (2020) (4)
- The definition and diagnostic testing of physical and cholinergic urticarias - EAACI/GA 2 LEN/EDF/UNEV consensus panel (2009) (4)
- Adrenaline autoinjector is underprescribed in typical cold urticaria patients (2022) (3)
- Dermographic urticaria symptoms can be safely prevented by ebastine (2007) (3)
- Anwendung von Biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen Covid-19-Pandemiea, b, c (2020) (3)
- Development of the Cold Urticaria Activity Score (2022) (3)
- Therapeutische Alternativen bei Antihistamintherapie-refraktärer Urtikaria (2010) (3)
- Identification of Biological and Pharmaceutical Mast Cell‐ and Basophil‐Related Targets (2016) (3)
- Idiopathic mast cell activation syndrome is more often suspected than diagnosed—A prospective real‐life study (2022) (3)
- Clinical Activity of AK002, an Anti-Siglec-8 Monoclonal Antibody, in Treatment-Refractory Chronic Urticaria (2020) (3)
- SUBCUTANEOUS SELF-ADMINISTRATION OF LANADELUMAB FOR PROPHYLACTIC TREATMENT IN PATIENTS WITH HEREDITARY ANGIOEDEMA (HAE) (2018) (3)
- Expert consensus on the use of omalizumab in chronic urticaria in China (2021) (3)
- Food-dependent cold urticaria: A new variant of physical urticaria. (2018) (3)
- Überzeugen oder Überreden (2008) (3)
- Novel aspects of mast cell and basophil function: Highlights from the 9th meeting of the European Mast Cell and Basophil Research Network (EMBRN)—A Marcus Wallenberg Symposium (2019) (3)
- Angioedema and prescribing of omalizumab for chronic urticaria in countries with limited financial resources (2019) (3)
- Urtikaria: „From bench to bedside“ (2007) (3)
- Ätiopathogenese der akuten und der chronischen Urtikaria (2006) (3)
- Pioneer: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Avapritinib in Patients with Indolent or Smoldering Systemic Mastocytosis with Symptoms Inadequately Controlled with Standard Therapy (2019) (3)
- The dermatology view of hereditary angio‐oedema: practical diagnostic and management considerations (2013) (3)
- NMR Solution Structure and Dynamics of the Peptidyl-prolyl cis – trans Isomerase Domain of the Trigger Factor from Mycoplasma genitalium Compared to FK 506-binding Protein (2002) (3)
- Food-dependent Exercise-induced Wheals, Angioedema, and Anaphylaxis: A Systematic Review. (2022) (3)
- Automatic screening of self‐evaluation apps for urticaria and angioedema shows a high unmet need (2021) (3)
- Langzeitprophylaxe des hereditären Angioödems mit Androgenderivaten: kritische Bewertung und mögliche Alternativen (2011) (3)
- Experience‐based advice on stepping up and stepping down the therapeutic management of chronic spontaneous urticaria: Where is the guidance? (2022) (3)
- MOTOR: Model assisted software for NMR structure determination (2013) (3)
- Efficacy Of Omalizumab In Patients With Chronic Idiopathic/Spontaneous Urticaria With Different Background Therapy: Post Hoc Analysis Of Asteria I, Asteria II, and Glacial Studies (2014) (3)
- Phase 2 Randomized Clinical Trial of Astegolimab in Patients with Moderate to Severe Atopic Dermatitis. (2022) (3)
- Mast cells in health and disease: from basic science to clinical application (2008) (3)
- Mast cells in health and disease: from basic science to clinical application 4-5 July 2008, Stuttgart, Germany. (2008) (3)
- The Arabic Urticaria Activity Score and Chronic Urticaria Quality of Life Questionnaire: validation and correlations (2020) (3)
- Advances in Brief p 53 Is Essential for Chemotherapy-induced Hair Loss 1 (2000) (3)
- Instrumente zur Erfassung von Krankheitsaktivität, Krankheitskontrolle und Lebensqualitätsbeeinträchtigung bei Patienten mit chronischer Urtikaria und Angioödemen (2016) (3)
- Cryoglobulins, Cryofibrinogens, and Cold Agglutinins in Cold Urticaria: Literature Review, Retrospective Patient Analysis, and Observational Study in 49 Patients (2021) (3)
- Using an extended treatment regimen of lanadelumab in the prophylaxis of hereditary angioedema: a single-centre experience (2022) (2)
- Remibrutinib (LOU064) Versus Placebo in Patients with Chronic Spontaneous Urticaria: A Randomised, Double-Blind, Phase 2b Dose-Finding Study (2021) (2)
- Validity, reliability, and interpretability of the Brazilian urticaria control test. (2020) (2)
- Importance of angioedema-free days in patients with chronic idiopathic or spontaneous urticaria. (2017) (2)
- Evidence for histamine release in chronic inducible urticaria – A systematic review (2022) (2)
- Urticaria and Angioedema: Understanding Complex Pathomechanisms to Facilitate Patient Communication, Disease Management, and Future Treatment. (2023) (2)
- Anti‐KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria (2022) (2)
- Therapeutic monoclonal antibodies with a focus on hereditary angioedema. (2022) (2)
- The Number of MRGPRX2-Expressing Cells Is Increased in Skin Lesions of Patients With Indolent Systemic Mastocytosis, But Is Not Linked to Symptom Severity (2022) (2)
- Attack-Free Status of Patients With Hereditary Angioedema (HAE) During Extended Treatment With Lanadelumab in the HELP OLE Study (2020) (2)
- Exaggerated neurophysiological responses to stressor in patients with chronic spontaneous urticaria (2021) (2)
- Chronic urticaria patients are interested in apps to monitor their disease activity and control: A UCARE CURICT analysis (2021) (2)
- Comparison of Direct Healthcare Costs Associated with Chronic Spontaneous /Idiopathic Urticaria in 7 Countries - Results from the Assure-CSU Study (2016) (2)
- Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: a systematic review for the EAACI Biologicals Guidelines (2020) (2)
- Erratum to: Looking forward to new targeted treatments for chronic spontaneous urticaria (2017) (2)
- Wytyczne EAACI/GA2LEN/EDF/WAO dotyczące definicji, klasyfikacji, diagnostyki i leczenia pokrzywki (2020) (2)
- Complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab (2022) (2)
- Gastrointestinal (GI) Adverse Events (AEs) Observed With Berotralstat (BCX7353) Treatment for Hereditary Angioedema (HAE) are Primarily Mild, Self-limited, and Diminish with Time on Treatment (2020) (2)
- Label-free imaging of macrophage phenotypes and phagocytic activity in the human dermis in vivo using two-photon excited FLIM (2021) (2)
- Adaptación transcultural del cuestionario Mastocytosis Quality of Life questionnaire (MC-QoL) del alemán al castellano (2020) (2)
- Mastocytoses (2019) (2)
- Remibrutinib Treatment Improves Quality of Life in Patients with Chronic Spontaneous Urticaria (2022) (2)
- Variability of disease activity in patients with hereditary angioedema type 1/2: longitudinal data from the Icatibant Outcome Survey (2021) (2)
- Characterization of cowhage‐induced pruritus in inflamed and non‐inflamed skin (2020) (2)
- Abstracts of the 32nd Spring Symposium of the German Society of Allergy and Clinical Immunology (2020) (2)
- Differential effects of skin nerves on allergic skin inflammation (2009) (2)
- HAE patient self-sampling for biomarker establishment (2021) (2)
- Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the Icatibant Outcome Survey, a cohort observational study (2018) (2)
- Unusual Structural Properties of a Complex of Calmodulin with a Binding Peptide of the Ca2+-Pump: A NMR Study. (1999) (2)
- Schröder gegen Merkel Das TV-Duell im Bundestagswahlkampf 2005 (2007) (2)
- Omalizumab Improves Quality of Life (QoL) in Patients with Refractory Chronic Spontaneous/Idiopathic Urticaria (CSU/CIU) As Assessed By the Dermatology Life Quality Index (DLQI): A Post-Hoc Analysis of Percent Change from Baseline to Week 12 (2015) (2)
- Identification of chronic urticaria subtypes using machine learning algorithms (2021) (2)
- Evaluation der bundesweiten Verkehrssicherheitskampagne "Runter vom Gas!" / Evaluation of the nation-wide traffic safety campaign "Runter vom Gas!" ("Down with speed!") (2012) (2)
- Leitlinie: Hereditäres Angioödem durch C1-Inhibitor-Mangel (2019) (2)
- Der Einfluss verbaler und visueller Informationen auf die Urteilsbildung über Politiker. (2013) (2)
- „Ich glaube, die Deutschen hassen mich“ (2008) (2)
- Allergen immunotherapy in the current COVID-19 pandemic - A position paper of the AeDA, ARIA, EAACI, DGAKI and GPA (2020) (2)
- Treatment of severe heat urticaria with omalizumab – report of a case and review of the literature (2020) (2)
- Chronische spontane Urtikaria – Ein Behandlungspfad für die Diagnosestellung und Therapie in der Praxis (2015) (2)
- Expertenkonsensus zu praxisrelevanten Aspekten bei der Behandlung der chronischen Urtikaria (2021) (2)
- „Das können Sie morgen in der Zeitung lesen“ (2015) (2)
- A novel approach for studying mast cell-driven disorders: mast cells derived from induced pluripotent stem cells. (2021) (2)
- Facharztprüfung Dermatologie und Venerologie, 1000 kommentierte Prüfungsfragen (2021) (2)
- Therapie von Patienten mit cholinergischer Urtikaria im Alltag in deutschsprachigen Ländern (2019) (2)
- Flare Size but Not Intensity Reflects Histamine-Induced Itch (2020) (2)
- Behandlung des hereditären Angioödems mit Lanadelumab in der deutschen Versorgungsrealität: Eine Analyse von Verordnungsdaten (2022) (2)
- Neue Urtikaria-Leitlinie — ein europäisches Empfehlungsgerüst (2011) (2)
- Diagnostik und Therapie der chronischen Urtikaria – Was wird von Revision und Aktualisierung der internationalen Leitlinie erwartet? (2013) (2)
- D102 BEROTRALSTAT REDUCES ATTACKS IN PATIENTS WITH HEREDITARY ANGIOEDEMA (HAE): APEX-2 TRIAL 48 WEEK RESULTS (2020) (2)
- Faculty Opinions recommendation of Heparin and tranexamic Acid therapy may be effective in treatment-resistant chronic urticaria with elevated d-dimer: a pilot study. (2010) (2)
- Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticaria (2022) (2)
- Kostenintensiv, zeitaufwendig, problematisch? – Die Betreuung von Urtikariapatienten aus der Perspektive niedergelassener Årzte (2012) (2)
- Effects of a Novel GA2LEN Training Program on Urticaria on the Knowledge of General Practitioners in Saudi-Arabia (2011) (2)
- Urticaria in Pregnancy and Lactation (2022) (2)
- Do mast cells play a role in hair follicle regression (catagen) (1994) (2)
- Acetylcholine-induced whealing in cholinergic urticaria - What does it tell us? (2021) (2)
- Journalismus und Agenda-Setting (2016) (2)
- Effects of levocetirizine and diphenhydramine on regional glucose metabolic changes and hemodynamic responses in the human prefrontal cortex during cognitive tasks (2018) (2)
- Dupilumab as a novel steroid-sparing treatment for hypereosinophilic syndrome (2022) (2)
- Up-dosing of Desloratadine Reduces Cold Provocation Test Responses in Patients with Cold Urticaria (2008) (1)
- Pharmacokinetics of Subcutaneous C1 Esterase Inhibitor (human) with Recombinant Human Hyaluronidase for the Prevention of Angioedema Attacks in Patients with Hereditary Angioedema (2015) (1)
- XXIX. Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (2002) (1)
- RELATIONSHIP OF TARGET CONCENTRATIONS WITH EFFICACY: RESULTS FROM THE APEX-1 STUDY OF BCX7353 (2018) (1)
- An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trial (2023) (1)
- Response to: ‘Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria: a critical appraisal’ (2014) (1)
- First Real-World Study Assessing Health Utility Values For Chronic Spontaneous/Idiopathic Urticaria Using The Eq-5d. (2015) (1)
- P68: Dupilumab provides improvement in sleep in children aged ≥ 6 years with severe atopic dermatitis (AD) and adolescents with moderate‐to‐severe AD (2021) (1)
- Chronic Urticaria: The Need for Improved Definition (2022) (1)
- In urticarial vasculitis, long disease duration, high symptom burden and high need for therapy are linked to low patient-reported quality of life. (2022) (1)
- Fazit: Medien und Wahlentscheidungen im Wahlkampf 2009 (2013) (1)
- Reply to "Proposal for a new classification of vibratory urticaria/angioedema". (2021) (1)
- Short communication The mast cell products histamine and serotonin stimulate and TNF-a inhibits the proliferation of murine epidermal keratinocytes in situ (1997) (1)
- “Chronic urticaria and obstructive sleep apnea: Is there a significant association?” (2021) (1)
- Early Versus Late Administration of Icatibant in Patients With Hereditary Angioedema (2017) (1)
- Long-term Impact of Lanadelumab on Patients with Hereditary Angioedema (HAE) Type 1/2: Patient Reported Outcome (PRO) Findings from the HELP Open-label Extension Study (OLE) (2021) (1)
- Effectiveness of lanadelumab for preventing hereditary angioedema attacks: Subgroup analyses from the HELP study (2021) (1)
- Author Correction: The Henna pigment Lawsone activates the Aryl Hydrocarbon Receptor and impacts skin homeostasis (2020) (1)
- P150 ORAL PROPHYLAXIS WITH BCX7353 REDUCES HAE ATTACK RATES AND IS WELL-TOLERATED: APEX-2 STUDY RESULTS (2019) (1)
- The Icatibant Outcome Survey: 10 years of experience with icatibant for patients with hereditary angioedema (2022) (1)
- P156 LONG-TERM LANADELUMAB TREATMENT IMPROVES HEALTH-RELATED QUALITY OF LIFE: HELP OPEN-LABEL EXTENSION STUDY INTERIM FINDINGS (2019) (1)
- Label-free imaging of M1 and M2 macrophage phenotypes in the human dermis in vivo using two-photon excited FLIM (2022) (1)
- Worsening of chronic spontaneous urticaria after intake of hot pepper. (2020) (1)
- [Cold-induced urticaria and angioedema. Classification, diagnosis and therapy]. (2010) (1)
- [Urticaria. "From bench to bedside"]. (2007) (1)
- Galectin-9 contributes to the pathogenesis of atopic dermatitis via T cell immunoglobulin mucin-3 (2022) (1)
- Viaggi e scoperte di navigalori ed esploratori italiani. (1)
- Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air® approach (2023) (1)
- 43nd Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung e.V. (ADF) (2016) (1)
- Rapid reduction in the size of mouse cutaneous mast cell populations by apoptosis after cessation of treatment with SCF does not result in skin inflammation (1998) (1)
- DUPILUMAB EFFICACY IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA BY IGE LEVEL: LIBERTY-CSU CUPID STUDY A (2022) (1)
- [Chronic spontaneous urticaria: An autoimmune disease?]. (2013) (1)
- Nutzen von Mepolizumab bei einer Patientin mit chronischer spontaner Urtikaria (2018) (1)
- Omalizumab in Chronic Inducible Urticaria: a Real-Life Study of Efficacy, Safety, Predictors of Treatment Outcome, Time to Response and Relapse (2021) (1)
- A Novel Method for Total IgE Purification from Human Serum (2022) (1)
- Realismus als Beruf (2013) (1)
- OR11-005 - Mast cells respond to pathogen signals with IL-1ß (2013) (1)
- Comparative Analysis of Indirect Costs Associated with Chronic Spontaneous/Idiopathic Urticaria-Results From The Assure-Csu Study In 7 Countries (2016) (1)
- Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advances (2022) (1)
- The Urticaria Control Test as a Tool for Monitoring Chronic Idiopathic/Spontaneous Urticaria Treatment: Results From XTEND-CIU, a 48-Week, Randomized, Placebo-controlled Study (2018) (1)
- Wähler unter Medieneinfluss. Berichterstattung, Meinungswandel und Medienwirkungen auf unterschiedlich involvierte Wählergruppen (2013) (1)
- Transcultural Adaptation of the German Mastocytosis Quality of Life Questionnaire (MC-QoL) into Spanish. (2020) (1)
- LANADELUMAB 300MG EVERY 2 WEEKS EFFECTIVELY PREVENTED HEREDITARY ANGIOEDEMA ATTACKS IN THE HELP STUDY (2018) (1)
- Treatment of acute attacks of hereditary angioedema ( HAE ) with the bradykinin B 2 receptor antagonist icatibant (2010) (1)
- Inhibition of Complex I of the Respiratory Chain, but Not Complex III, Attenuates Degranulation and Cytokine Secretion in Human Skin Mast Cells (2022) (1)
- Ligelizumab is more effective in patients with chronic spontaneous urticaria previously treated with omalizumab (2021) (1)
- Baseline Characteristics of Patients with Refractory Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU) Enrolled in a Phase III, Randomized, Placebo-Controlled Trial of Omalizumab (2013) (1)
- Omalizumab Improves Quality of Life (QoL) in Patients with Chronic Spontaneous/Idiopathic Urticaria (CSU/CIU) As Assessed By the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL): A Post-Hoc Analysis of Percent Change from Baseline to Week 12 (2015) (1)
- Transcriptional licensing is required for Pyrin inflammasome activation in human macrophages and bypassed by mutations causing familial Mediterranean fever (2022) (1)
- Validity and Responsiveness of Urticaria Activity and Impact Measure (U-AIM), a New Patient-Reported Tool to Assess Disease Activity and Impact in Patients with Chronic Spontaneous/Idiopathic Urticaria (CSU/CIU) (2018) (1)
- A Systematic Review of Aquagenic Urticaria - Subgroups and Treatment Options. (2022) (1)
- Attenuated androgen discontinuation in patients with hereditary angioedema: a commented case series (2022) (1)
- Efficacy and Safety of Omalizumab in Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU): Results From a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial (2013) (1)
- Reply to "Is anti-TPO IgG and total IgE clinically useful for the detection of autoimmune chronic spontaneous urticaria"? (2022) (1)
- Diagnostik und Therapie der chronischen Urtikaria – was wird von Revision und Aktualisierung der internationalen Leitlinie erwartet? (2013) (1)
- The first international study assessing the economic and humanistic burden of refractory chronic spontaneous/idiopathic urticaria (2014) (1)
- Assure-Csu: Assessing the Impact of Chronic Spontaneous / Idiopathic Urticaria on Work Productivity and Activity (2016) (1)
- A simple immunofluorescence-technique for co-visualizing mast cells and peptidergic nerve fibers in skin. (1995) (1)
- Mast cells and tryptase are linked to itch and disease severity in mycosis fungoides: Results of a pilot study (2022) (1)
- Hereditäres Angioödem: Update zu verfügbaren Therapieoptionen (2010) (1)
- Chronic spontaneous urticaria activity, impact and control as well as their changes are strongly linked, and these links are not affected by angioedema or comorbid inducible urticaria – Results from the validation of the Polish Urticaria Control Test (2022) (1)
- History of Misdiagnosis in Patients with Hereditary Angioedema Participating in the Icatibant Outcome Survey (2015) (1)
- Prozessevaluation der Kampagnenfortsetzung 2011-2012 „Runter vom Gas!" (2014) (1)
- Paasch-Colberg, Sünje: Die Bedeutung politischer Themen im Wahlkampf. Mediale Thematisierungswirkungen im Bundestagswahlkampf 2009 (2017) (1)
- „Das können Sie morgen in der Zeitung lesen“ (2015) (1)
- Icatibant Treatment of Acute Attacks in Pediatric Patients With Hereditary Angioedema: Findings from the Icatibant Outcome Survey: 127 (2019) (1)
- Association of Chronic Urticaria with Psychological Distress: A Multicentre Cross-sectional Study (2022) (1)
- Antihistamines in atopic dermatitis (2007) (1)
- Autoreaktive Urtikaria und Autoimmunurtikaria : Urtikaria (2004) (1)
- Kälteinduzierte Quaddeln und Angioödeme (2010) (1)
- Food-Dependent and Food-Exacerbated Symptomatic Dermographism: New Variants of Symptomatic Dermographism. (2021) (1)
- Impaired sweating in patients with cholinergic urticaria is linked to low expression of acetylcholine receptor CHRM3 and acetylcholine esterase in sweat glands (2022) (1)
- Spätentscheider und Medienwirkungen in Wahlkämpfen (2013) (1)
- P155 SLEEP AND QUALITY OF LIFE IMPROVES WITH BETTER CONTROL OF URTICARIA SYMPTOMS: LIGELIZUMAB PHASE-2B STUDIES (2020) (1)
- Red and itchy bilateral supraorbital swellings (2018) (1)
- Oral Prophylaxis with Berotralstat (BCX7353) Reduces Use of Standard of Care (SOC) On-demand Medication in Patients with Hereditary Angioedema (HAE): APeX-2 Study Results (2020) (1)
- P157 ATTACK-FREE STATUS DURING EXTENDED TREATMENT WITH LANADELUMAB FOR HEREDITARY ANGIOEDEMA: HELP OLE STUDY FINAL RESULTS (2020) (1)
- Grundlagen: Designs und Forschungslogik in der Medienwirkungsforschung (2013) (1)
- Verbesserung der Prozesse rund um den radiologischen Arbeitsplatz (2014) (1)
- Label-free imaging of macrophage phenotypes and phagocytic activity in the human dermis 1 in vivo using two-photon excited FLIM 2 (2021) (0)
- Joint Symposium DGAKI/EAACI Imunology Section: Immunology of Allergic Reactions (2007) (0)
- Modulation of skin mast cell functions in situ by neurotrophin-3 (1998) (0)
- 17in atopic dermatitis (2007) (0)
- Health-Related Quality of Life (HRQoL) in Pediatric Patients with Hereditary Angioedema (HAE) Receiving Lanadelumab: Exploratory Results From the SPRING Study (2023) (0)
- 531 Human skin mast cells express photoreceptors (2016) (0)
- Omalizumab Improves Angioedema-Related Quality of Life Impariment in Patients with Chronic Idiopathic/Chronic Spontaneous Urticaria: Results from the X-Act Study (2018) (0)
- 2.3 Mykosen (2014) (0)
- Faculty Opinions recommendation of Candida spp. colonization and serum anticandidal antibody levels in patients with chronic urticaria. (2008) (0)
- 25444 Ligelizumab further reduced sleep impairment in patients with chronic spontaneous urticaria previously treated with omalizumab (2021) (0)
- Contents Vol. 155, 2011 (2011) (0)
- C URRENT OPINION Immunoregulation in cutaneous allergy: prevention and control (2012) (0)
- Ecology and Distribution of Sand Fly Species of Mokolo, an Endemic Focus of Cutaneous Leishmaniasis in Cameroon (2022) (0)
- 114 IL-15 Constrains Mast Cell-dependent Anti-bacterial Defenses by Suppressing Chymase Activities (2007) (0)
- Characterization Of Hereditary Angioedema Attacks Requiring Reinjection Of Icatibant: Findings From The Icatibant Outcome Survey (2018) (0)
- EL12 Urticaria-pathogenesis and treatment (2013) (0)
- University of Southern Denmark Efficacy and safety of omalizumab in patients with chronic idiopathic / spontaneous urticaria who remain symptomatic on H 1 antihistamines a randomized , placebo-controlled study (2010) (0)
- F1000Prime recommendation of Usefulness of a short course of oral prednisone in antihistamine-resistant chronic urticaria: a retrospective analysis. (2010) (0)
- Ligelizumab for adolescent patients with CSU: first results from a dedicated Phase 2b study (2022) (0)
- Reply to Wood et al. (2019) (0)
- Faculty Opinions recommendation of Pimecrolimus induces apoptosis of mast cells in a murine model of cutaneous mastocytosis. (2010) (0)
- Contents Vol. 167, 2015 (2015) (0)
- Efficacy And Safety Of Bradykinin B2 Receptor Inhibition With Oral PHVS416 In Treating Hereditary Angioedema Attacks: Results Of RAPIDe-1 Phase 2 Trial (2023) (0)
- Disease Impact, Diagnostic Delay, and Unmet Medical Needs of Patients With Cholinergic Urticaria in German-Speaking Countries (2022) (0)
- Impairedmast cell-dependent natural immunity in complementC 3-deficientmice (0)
- 6.3 Dermatomyositis (2014) (0)
- Chronic Urticaria (2021) (0)
- Cells Are Resident in Normal Skin'' Comment on ''The Vast Majority of CLA (2006) (0)
- Clinical Efficacy and Outcomes of Remibrutinib (LOU064) in Patients with Chronic Spontaneous Urticaria Inadequately Controlled with H1-Antihistamines: Findings from a Phase IIb Study (2022) (0)
- Remibrutinib Improves Chronic Spontaneous Urticaria in Patients Irrespective of Previous Anti-IgE Treatment: Results From a Phase 2b Study (2023) (0)
- Faculty Opinions recommendation of Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. (2009) (0)
- CHRONIC SPONTANEOUS URTICARIA: THE ROLE AND RELEVANCE OF AUTOREACTIVITY, AUTOIMMUNITY AND AUTOALLERGY. (2023) (0)
- 日本人健康ボランティアのレボセチリジン,フェキソフェナジン,ジフェンヒドラミン投与が模擬自動車運転能力に与える影響 (2015) (0)
- S9-1 Treatment of refractory urticaria with anti IgE antibody (2013) (0)
- 4.2 Andere erythrosquamöse Dermatosen (2014) (0)
- Subcutaneous administration of human C1 inhibitor with recombinant human hyaluronidase in patients with hereditary angioedema. (2016) (0)
- Soluble IgE‐binding factors in the serum of food‐allergic patients: Possible pathophysiological role of soluble FcεRI as protective factor (2023) (0)
- Long-Term Efficacy and Safety of Omalizumab Monotherapy in a Patient With Normocomplementemic Urticarial Vasculitis. (2022) (0)
- Avapritinib Improved Symptoms and Quality of Life in Patients With Indolent Systemic Mastocytosis in the PIONEER Study (2023) (0)
- The Aryl Hydrocarbon Receptor senses the Henna pigment Lawsone and mediates Yin-Yang effects on skin homeostasis (2018) (0)
- Potential Mechanism for Mast Cell Activation Responses to Acute Septic Peritonitis: A A Role for CD21/CD35 and CD19 in (2000) (0)
- 4.1 Psoriasis (2014) (0)
- Asymmetry of the Receding Hairline in Men With Early Androgenetic Alopecia (2016) (0)
- Relative Reductions in Attack Rate With Prophylactic Berotralstat (BCX7353) in Subjects with Hereditary Angioedema (HAE): Responder Analysis from the APeX-2 Study (2020) (0)
- An EU task force to assess the burden of rare diseases (2023) (0)
- The Road to Better Urticaria and Angioedema Management. (2021) (0)
- ALLERGIC DERMATOSIS AND URTICARIA ( J RING , SECTION EDITOR ) Physical Urticaria (2012) (0)
- FRT – FONDATION RENE TOURAINE (2015) (0)
- CD 11 b / CD 18 , CR 3 )-Deficient Mice Development and Innate Immunity in Mac-1 Cutting Edge : Impaired Mast Cell (1998) (0)
- Gene polymorphisms of tumor necrosis factor !-308 and interleukin 10-1082 among asthmatic Egyptian children (2007) (0)
- Non-allergenic mediators from pollen induce mast cell dependent skin inflammation (2009) (0)
- Translation and Cultural Adaptation of the German Mastocytosis Quality of Life Questionnaire (MC-QoL) Into Spanish (2020) (0)
- Lidocaine/prilocaine-treated skin modulate allergic inflammation induced by skin prick test (2007) (0)
- Bovet’s Nobel Prize-winning discovery of antihistamines (2013) (0)
- What is new and upcoming in the world of chronic urticaria? (2016) (0)
- LB1587 Cryptochromes and opsins in human mast cells: putative regulators of their functionality (2018) (0)
- Treatment of Hereditary Angioedema Attacks with Icatibant: A Comparison of Observational Data with Clinical Trial Data (2013) (0)
- Author Correction: The Henna pigment Lawsone activates the Aryl Hydrocarbon Receptor and impacts skin homeostasis (2020) (0)
- Other Interventions for Chronic Urticaria (2021) (0)
- 501 Mechanisms of mast cell and T cell interactions during skin infections (2017) (0)
- In Chronic Spontaneous Urticaria, Complete Response to Antihistamine Treatment Is Linked to Low Disease Activity. (2023) (0)
- Controversies in Experimental Dermatology (2006) (0)
- Clinical review: The suggested management pathway for urticaria in primary care (2022) (0)
- 3 rd Autoinflammation Masterclass of the Autoinflammation Reference Center Charité (ARC²) September, 25-26 th , 2014 (2014) (0)
- D100 LIGELIZUMAB ACHIEVES FAST CONTROL OF SYMPTOMS IN MORE PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA VERSUS OMALIZUMAB (2020) (0)
- Efficacy of lanadelumab at fixed and modified dosing regimens in patients aged 2 to <12 years old with hereditary angioedema (HAE) in the phase 3, open-label, multicenter SPRING Study (2023) (0)
- Contents Vol. 169, 2016 (2016) (0)
- Antihistamines in the Treatment (2010) (0)
- Iconography : IL-24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria (2018) (0)
- Erratum (2005) (0)
- IL-9 Production by Regulatory T Cells Recruits Mast Cells That Are Essential for Regulatory T Cell-Induced Immune-Suppression (2010) (0)
- An Overview of Mechanisms of Histamine- and Non-Histamine-Mediated Angioedema (2018) (0)
- The benefit of complete response to treatment in patients with chronic spontaneous urticaria - CURE results. (2022) (0)
- Gender Analysis of Icatibant-Treatment Outcomes of Acute Angioedema Attacks in Patients with Hereditary Angioedema Type I and II: Results from the Icatibant Outcome Survey (2016) (0)
- Bradykinin in health and disease: proceedings of the Bradykinin Symposium 2012, Berlin 23–24 August 2012 (2013) (0)
- Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria: Results from the Phase-3 Pivotal Trials (2023) (0)
- O005 Improvement in hereditary angioedema diagnosis: Findings from the icatibant outcome survey (2016) (0)
- The role of innate immunity in asthma: leads and lessons from (2007) (0)
- Breakthrough in the Understanding of the Anti-IgE Pathway in Chronic Spontaneous Urticaria and the Potential of Ligelizumab (2020) (0)
- Mast cells cultured from IL-3-treated mice show impaired responses to bacterial antigen stimulation (2011) (0)
- Commentary 8 (2005) (0)
- Efficacy and Safety of Avapritinib in Indolent Systemic Mastocytosis (ISM): Results from the Double Blinded Placebo-Controlled PIONEER Study (2023) (0)
- Evaluation of the Reliability and Validity of the Persian Version of Urticaria Control Test (UCT). (2021) (0)
- 21. Mainzer Allergie-Workshop (2009) (0)
- S3 Guideline Urticaria. Part 1: Classification and diagnosis of urticaria – German‐language adaptation of the international S3 Guideline (2023) (0)
- MRGPRX2 in drug allergy: What we know and what we do not know. (2022) (0)
- Comment on “Mast Cell-Mediated Remodeling and Fibrinolytic Activity Protect against Fatal Glomerulonephritis” (2006) (0)
- Worldwide Challenges for Evaluation and Treatment of Hereditary Angioedema (2018) (0)
- How does experience affect Management of Chronic Spontaneous Urticaria? A cross sectional study in Latin America (2017) (0)
- Assessment of chronic spontaneous urticaria by serum-induced tumor necrosis factor alpha and matrix metalloproteinase-9 release (2012) (0)
- Epidemiology, management and treatment access of hereditary angioedema in the Asia Pacific Region: outcomes from an international survey. (2022) (0)
- Management Principles in Urticaria (2021) (0)
- P507 BCX7353: An effective and safe oral prophylaxis against attacks of hereditary angioedema. apex-1 final results (2017) (0)
- Chapter-04 Diagnosis of Urticaria (2018) (0)
- Use of biologics in allergic and type 2 inflammatory diseases in the current Covid 19 pandemic(a, b, c) (2020) (0)
- Inhibition of interleukin‐1 with rilonacept is not effective in cold urticaria—Results of a randomized, placebo‐controlled study (2023) (0)
- The validity and reliability of a Thai version of the Angioedema Control Test: Which recall period is preferable? (2023) (0)
- The Icatibant Outcome Survey: Characteristics Of Patients With Hereditary Angioedema Requiring Reinjection (2014) (0)
- Patient-centred digital biomarkers for allergic respiratory diseases and asthma: the ARIA-EAACI approach. (2023) (0)
- Corrigendum to "Inventory and taxonomy of phlebotomine sand flies of the Mokolo leishmaniasis focus, northern Cameroon, with description of new Sergentomyia taxa (Diptera: Psychodidae)" [Acta Trop. 194 (2019) 172-180]. (2020) (0)
- Real World treatment patterns of hereditary angioedema with lanadelumab in Germany: A prescription data analysis (2022) (0)
- in press Metz et al.,Retreatm. Omalizumab in CSU.JAMA Derm 2014 (2014) (0)
- Abstracts of the 40th Annual Meeting of the European Society for Dermatological Research. September 9-11, 2010. Helsinki, Finland. (2010) (0)
- Reply to the letter to the editor on: "In psoriasis, levels of hope and quality of life are linked". (2016) (0)
- Author index (2005) (0)
- The Henna pigment Lawsone activates the Aryl Hydrocarbon Receptor and impacts skin homeostasis (2019) (0)
- Viewpoint 5 (2006) (0)
- Total IgE levels are linked to the course of chronic spontaneous urticaria during pregnancy. (2022) (0)
- Notes from the 37th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF), Berlin, www.adf‐online.de (2010) (0)
- Avapritinib Improved Skin Findings In Patients With Indolent Systemic Mastocytosis (ISM) In the Registrational, Double-Blind, Placebo Controlled PIONEER Study (2023) (0)
- Ligelizumab Achieves Freedom from Signs and Symptoms of Chronic Spontaneous Urticaria Regardless of the CU Index (Basophil Histamine Release Assay) Status at Baseline (2022) (0)
- 769 Murine skin mast cells release histamine after stimulation with vanilloids In vitro (1996) (0)
- 11.1 Akne (2014) (0)
- Most patients with autoimmune chronic spontaneous urticaria also have autoallergic urticaria, but not vice versa. (2023) (0)
- The Icatibant Outcome Survey: Observational Data in Patients with Angioedema Due to Acquired C1 Inhibitor (C1-INH) Deficiency (2015) (0)
- Role of CD35 in the complement-dependent activation of mast cells (1998) (0)
- The Icatibant Outcome Survey: More Than 1500 Icatibant-Treated Attacks in Patients with Type I or II Hereditary Angioedema (2015) (0)
- Update of the Guideline on Chronic Urticaria (2014) (0)
- Managing Urticaria: New Guidelines and Beyond (2015) (0)
- Analysis of genetic impact on smell impairment in patients with hereditary angioedema type 1 and 2 (2021) (0)
- Sustained Improvement in Work Productivity and Activity Impairment in Chronic Spontaneous Urticaria (CSU) Patients with Omalizumab: Results from Xtend-CIU (2018) (0)
- Ligelizumab for Chronic Spontaneous Urticaria. Reply. (2020) (0)
- Pharmacokinetic equivalence of CT‐P39 and reference omalizumab in healthy individuals: A randomised, double‐blind, parallel‐group, Phase 1 trial (2022) (0)
- Chronic spontaneous and inducible urticaria 2 (2020) (0)
- Dupilumab Improves Urticaria Activity And Quality Of Life In Patients With Chronic Spontaneous Urticaria (CSU) (2023) (0)
- The Mexican Guidelines on Urticaria (2014) (0)
- 041 Prevalence, characteristics and burden of pruritus in chronic dermatoses (2017) (0)
- Possession of epinephrine auto-injectors by Canadians with food allergies (2011) (0)
- Stepping Down Treatment in Chronic Spontaneous Urticaria: What We Know and What We Don't Know. (2023) (0)
- Interleukin‐2‐Soforttyp‐Allergie? (2008) (0)
- 649 OX40/OX40L and 4-1BB/4-1BBL signaling in cutaneous anti-tumoral immunity (2016) (0)
- P164 Longitudinal natural history of patients with type I/II hereditary angioedema: icatibant outcome survey data (2017) (0)
- Subject Index Vol. 155, 2011 (2011) (0)
- The Icatibant Outcome Survey: Characterizing Breakthrough Hereditary Angioedema Attacks In Patients Receiving Long-Term Prophylaxis (2014) (0)
- 057 The role of substance P and its receptor NK1R in chronic prurigo: Results from a randomized, controlled trial with topical aprepitant (2017) (0)
- 166 Assessment of Chronic Spontaneous Urticaria by Serum-Induced TNF & ALPHA; and MMP-9 Release (2012) (0)
- 040 Updosing of non sedating antihistamines can improve the treatment of patients with cholinergic urticaria (2016) (0)
- Assessing Health-Utility Values for Chronic Spontaneous/Idiopathic Urticaria In Real-World Using The EQ-5D: Results From Assure-Csu Study (2016) (0)
- P161 Urticaria activity and impact measure (U-aim) evaluates CSU/CIU activity, impact, and control in clinical practice (2017) (0)
- Control of murine hair follicle regression (catagen) by TGF- b 1 in vivo hair follicle (2000) (0)
- Supplemental material: Spindler et al., Sleep disturbance in adult dermatological patients: A cross-sectional study on prevalence, burden and associated factors, J Am. Acad Dermatol (2021) (0)
- 27362 High rate of complete response achieved with ligelizumab in patients with moderate to severe chronic spontaneous urticaria throughout the phase 2b core study (2021) (0)
- P153 COMPLETE CONTROL OF URTICARIA SYMPTOMS WITH LIGELIZUMAB HELPS NORMALIZE QUALITY OF LIFE (2020) (0)
- Low and high IgE is linked to improvement and worsening of chronic urticaria during pregnancy, respectively (2021) (0)
- Murine hair cycle-dependent changes of mast cell histochemistry in murine skin (1994) (0)
- Skin'' T Cells Are Resident in Normal + of CLA Response to Comment on ''The Vast Majority (2006) (0)
- Utility of Biologics for Antihistamine-Resistant Chronic Spontaneous Urticaria (2018) (0)
- Virus‐infected Mast Cells activate Virus‐specific CD8 + T Cells (2023) (0)
- Interleukin-1-related cytokines as potential biomarkers in autoinflammatory skin diseases (2015) (0)
- Chronic Spontaneous Urticaria and Comorbidities (2021) (0)
- STAT3 gain-of-function is not responsible for low total IgE levels in patients with autoimmune chronic spontaneous urticaria (2022) (0)
- Chronic Spontaneous Urticaria (2021) (0)
- S3 Guideline Urticaria. Part 2: Treatment of urticaria – German‐language adaptation of the international S3 guideline (2023) (0)
- Mast Cell Biology and Its Role in the Immediate Skin Contact Reactions (2014) (0)
- One in five patients with chronic spontaneous urticaria has IgE to tissue transglutaminase 2. (2023) (0)
- The Icatibant Outcome Survey: Trigger Factors and Premonitory Symptoms of Angioedema Attacks in Patients with Hereditary Angioedema (2015) (0)
- The Icatibant Outcome Survey: Rate and Impact Of Treatment By Self-Administration (2014) (0)
- Patients with hereditary angioedema and their treatment patterns in Germany: a Delphi consensus study (2022) (0)
- Development of tripe palms and soles in a patient with long pre‐existing systemic mastocytosis and newly developed non‐small cell lung cancer (2018) (0)
- D101 EFFICACY OF LIGELIZUMAB IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA INADEQUATELY CONTROLLED WITH OMALIZUMAB (2020) (0)
- Early treatment with icatibant significantly reduces duration and time to resolution of hereditary angioedema attacks: 129 (2013) (0)
- Adrenaline autoinjector is under-prescribed in typical cold urticaria patients living in tropical climate countries (2022) (0)
- Chronic spontaneous urticaria guidelines: What is new? (2022) (0)
- Front & Back Matter (2012) (0)
- Reply to Ensina et al (2018) (0)
- Iconography : The XTEND-CIU study: Long-term use of omalizumab in chronic idiopathic urticaria (2017) (0)
- O004 Childhood presenting hereditary angioedema is diagnosed in adulthood by non-pediatric physicians: Icatibant outcome survey findings (2016) (0)
- 8.8 Kutane Lymphome (2014) (0)
- A simple organ culture system for studying mast cell-dependent neuroimmune interactions in skin: Mast cell degranulation in situ by β-endorphin and substance P (1994) (0)
- Long-term lanadelumab treatment improves health-related quality of life in patients with hereditary angioedema. (2023) (0)
- Ligelizumab Improves Dermatology Quality Of Life In Patients With Chronic Spontaneous Urticaria Regardless of Angioedema Status At Baseline (2022) (0)
- 11.2 Rosazea (2014) (0)
- 33004 Dupilumab significantly reduces itch and hives in patients with chronic spontaneous urticaria (CSU) who remain symptomatic despite use of standard-of-care antihistamines: Results from a phase 3 trial (LIBERTY-CSU CUPID study A) (2022) (0)
- 416 Dopamine agonists block mast cell degranulation (2016) (0)
- 2.4 Würmer (2014) (0)
- 4.3 Lichenoide Dermatosen (2014) (0)
- Omalizumab in the Treatment of Urticaria (2021) (0)
- cddis2012214 Supplementary Information (2014) (0)
- Abstract CT168: Changes in mast cell (MC) numbers and phenotype in patients (pts) with indolent systemic mastocytosis (ISM) treated with avapritinib (2021) (0)
- Case report: Recurrent angioedema: Diagnosing the rare and the frequent (2022) (0)
- Comprar Urticaria and Angioedema | Zuberbier, Torsten | 9783540790471 | Springer (2010) (0)
- Physical urticaria: clinical features, pathogenesis, diagnostic work-up, and management. (2023) (0)
- against Fatal Glomerulonephritis'' Remodeling and Fibrinolytic Activity Protect Comment on ''Mast Cell-Mediated (2006) (0)
- Eating increases and exercise decreases disease activity in patients with symptomatic dermographism. (2022) (0)
- Contents Vol. 165, 2014 (2015) (0)
- Treatment patterns and outcomes in patients with chronic urticaria during pregnancy: Results of PREG‐CU, a UCARE study (2022) (0)
- Benefits of Early Administration with Icatibant for the Treatment of Hereditary Angioedema Attacks (2013) (0)
- A Simulated Car-driving Performance on the Effects of Administration of Levocetirizine, Fexofenadine, and Diphenhydramine in Healthy Japanese Volunteers (2015) (0)
- Expert consensus on prophylactic treatment of hereditary angioedema (2022) (0)
- Interleukin‐2 immediate type hypersensitivity? (2008) (0)
- Novel microparticles create a slow releasing depot for long-term immunostimulation in allergen-specific immunotherapy (2016) (0)
- Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria- a systematic review for the EAACI Biologicals Guidelines (2020) (0)
- Searching for Genetic Biomarkers for Hereditary Angioedema Due to C1-Inhibitor Deficiency (C1-INH-HAE) (2022) (0)
- Supplementary Material for: Positive CD63 Basophil Activation Tests Are Common in Children with Chronic Spontaneous Urticaria and Linked to High Disease Activity (2016) (0)
- Prevention of signs and symptoms of cold urticaria by ebastine (2007) (0)
- Safety and Clinical Activity of Multiple Doses of Barzolvolimab, an anti-KIT Antibody, in Patients with Chronic Spontaneous Urticaria (2023) (0)
- Berotralstat Improved Quality of Life through 96 Weeks Across Multiple Subgroups of Patients with Hereditary Angioedema (2023) (0)
- Chronic urticaria - why are patients dissatisfied with treatment? (2007) (0)
- Early macrophage influx to sites of cutaneous granuloma formation is dependent on MIP-1 (cid:1) / (cid:2) released from neutrophils recruited by mast cell–derived TNF (cid:1) (2002) (0)
- Assessment of urticaria using a self‐reported diagnosis tool (SRUD): a multicentre validation study (2021) (0)
- Consensus on diagnosis and management of Hereditary Angioedema in the Middle East: A Delphi initiative (2022) (0)
- Faculty Opinions recommendation of Striking effect of the IL-1 receptor antagonist anakinra in chronic urticarial rash with polyclonal increase in IgA and IgG. (2007) (0)
- Faculty Opinions recommendation of The use of mycophenolate mofetil for the treatment of autoimmune and chronic idiopathic urticaria: experience in 19 patients. (2012) (0)
- Regulatory T Cell-Induced Immune Recruits Mast Cells That Are Essential for IL-9 Production by Regulatory T Cells (2010) (0)
- Chronic spontaneous urticaria patients are still undertreated: One-year data from the AWARE study (2018) (0)
- Investigative dermatology: where do we stand and where do we go? (2010) (0)
- Food-dependent exercise-induced wheals/angioedema, anaphylaxis, or both: A systematic review of phenotypes. (2023) (0)
- In this issue: Graphical abstract (2022) (0)
- Les Conestoya en Pennsylvanie. (0)
- Las directrices mexicanas sobre urticaria (2014) (0)
- ¿Un círculo virtuoso para todos? Exposición mediática y confianza política en Europa (2009) (0)
- 13 Erkrankungen der Mundschleimhaut (2014) (0)
- Paasch-Colberg, Sünje: Die Bedeutung politischer Themen im Wahlkampf. Mediale Thematisierungswirkungen im Bundestagswahlkampf 2009 (2017) (0)
- Ligelizumab als Add-on-Therapie für Patienten mit H1-Antihistaminika-refraktärer chronischer spontaner Urtikaria: Primäre Ergebnisse einer placebo- und wirkstoffkontrollierten Dosisfindungsstudie der Phase IIb (2020) (0)
- Notes from the Arbeitsgemeinschaft Dermatologische Forschung (ADF), Berlin, http://www.adf‐online.de (2009) (0)
- Erfolgreiche Behandlung mit Mepolizumab bei einem Patienten mit therapieresistentem Wells‐Syndrom (2020) (0)
- Erratum to: XXIX. Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (2002) (0)
- Inszenierte Schlüsselereignisse: Die Medienresonanz der Verkehrssicherheitskampagne Runter vom Gas! (2015) (0)
- Pathomechanismus von Angioödemen (2013) (0)
- Inkonsistent einseitig (2023) (0)
- 15. Mainzer Allergie-Workshop 2003 (2003) (0)
- 15. Mainzer Allergie-Workshop 2003 (2003) (0)
- Mastzellen sind nicht immer die „bad guys“ (2011) (0)
- Allergien in den Griff bekommen: Frühzeitig behandeln — Spätfolgen vermeiden (2013) (0)
- 2.1 Bakterielle Infektionen (2014) (0)
- Wie Menschen zukünftige Temperaturveränderungen durch den Klimawandel einschätzen (2020) (0)
- Die Wirkungen von Fernsehdebatten (2003) (0)
- Infektiöse Reisedermatosen (2020) (0)
- 5. Kritik / Weiterentwicklungen (2010) (0)
- Nonverbale Kommunikation in der Politik (2016) (0)
- Externe Einflüsse I: Wahlkampf und TV-Duell (2013) (0)
- Nonverbale politische Kommunikation: Definitionen und Grundlagen (2016) (0)
- Die Wirkung nonverbaler Kommunikation auf die politische Meinungsbildung (2016) (0)
- 3. Forschungslogik der Methode (2010) (0)
- Die TV-Duelle im Bundestagswahlkampf 2002: Entstehung und Ausgangslage (2003) (0)
- 4.7 Pruritus und Prurigo (2014) (0)
- Use of biologicals in allergic and type 2 inflammatory diseases in the current COVID-19 pandemic/ Anwendung von biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen COVID-19-Pandemie (2020) (0)
- 4.5 Granulomatöse Hauterkrankungen (2014) (0)
- Vetbale und visuelle Informationen in den Femsehnachrichten VOt den Bundestagswahlen 1998 und 2002 (2003) (0)
- Urtikaria: Was gibt’s Neues? Biologika und mehr… (2019) (0)
- Verkehrssicherheitskommunikation: Definition und Herangehensweisen (2015) (0)
- Untersuchung genetischer Einflüsse auf Riechstörungen bei Patienten mit hereditärem Angioödem Typ 1 und 2 (2021) (0)
- Lkw-Parkmanagementsystem auf BAB in Bayern am Beispiel der Park- und Rastanlage in Offenbau / Intelligent truck parking management for German motorways tested on Bavarian parking and rest area "Offenbau" (2012) (0)
- Auf den Spuren der Lügenpresse (2018) (0)
- Symposium 4: Die Mastzelle (2007) (0)
- 1.7 Intoleranzreaktionen auf Medikamente (2014) (0)
- 6.1 Lupus erythematodes Quelle: Kuhn et al. 2009, 2011, 2012 (2014) (0)
- 5.3 Weitere bullöse Autoimmundermatosen mit Spaltbildung unterhalb der Lamina densa (2014) (0)
- 8.5 Fettgewebstumoren (2014) (0)
- 8. „Top Ten“ der Forschungsliteratur (2010) (0)
- Evaluation der Kampagnenfortsetzung 2013/2014 "Runter vom Gas" (2017) (0)
- 8.4 Gefäßtumoren (2014) (0)
- 2. Entwicklungsgeschichte des Ansatzes (2010) (0)
- Zusammenfassung: Nutzung, Wahrnehmung und Wirkung der TV-Duelle im Bundestagswahlkampf 2002 (2003) (0)
- Einfluss der Genese von Urtikaria-Subtypen auf die bronchiale Hyperreagibilität (2005) (0)
- Eigenblutbehandlung bei Urtikaria (2019) (0)
- 6.2 Sklerodermie (2014) (0)
- Communication research matters — Bericht von der 51. Jahrestagung der ICA in Washington D.C. (2001) (0)
- Gemeinsame Pathogenese — gemeinsame Therapiestrategien? (2011) (0)
- 1. Grundzüge der Theorie (2010) (0)
- 1.3 Berufsdermatosen (2014) (0)
- Generelle Überredbarkeit: Gibt es den fernsehgläubigen Wähler? (2005) (0)
- Verdachtsdiagnose durch Labordiagnostik bestätigen (2012) (0)
- 10 Erkrankungen der Haare und Nägel (2014) (0)
- Evaluation der Berufsbildungsaktivitäten der DEZA (2011) (0)
- 1.4 Figurierte Erytheme (2014) (0)
- INTOLERANZREAKTION AUF SYSTEMISCHE KORTIKOSTEROIDE (1997) (0)
- Chronische spontane Urtikaria (2013) (0)
- 8.3 Bindegewebstumoren (2014) (0)
- Argumentation Mining: Eine neue Methode zur automatisierten Textanalyse und ihre Anwendung in der Kommunikationswissenschaft (2017) (0)
- 2.2 Virusinfektionen (2014) (0)
- Notes from the Arbeitsgemeinschaft Dermatologische Forschung (ADF), Berlin, http://www.adf‐online.de (2008) (0)
- Einsatz von Biologika bei chronischer spontaner Urtikaria – auch jenseits einer Omalizumab-Therapie? (2021) (0)
- Wiederkehrende Angioödeme – wie messe und kontrolliere ich das Ansprechen auf Therapie? (2019) (0)
- 18.1 Diabetes, Schilddrüsen- und chronisch entzündliche Darmerkrankungen (2014) (0)
- Die Wirkungen des zweiten TV-Duells (2003) (0)
- 1.5 Erythema exsudativum multiforme, Stevens-Johnson-Syndrom, Lyell-Syndrom (2014) (0)
- Anlage der Untersuchung (2019) (0)
- Eine kurze Geschichte der Fernsehdebatten... (2003) (0)
- Der Ort der Kontrolle. Zum Einfluß interner und externer Faktoren auf die Wahlentscheidung (2001) (0)
- Die Bedeutung der Kandidaten für das Wahlverhalten (2003) (0)
- Dokumentation und Evaluation der Weiterbildung Contents of Forthcoming Issues · Themenvorschau (2016) (0)
- Wissenswerte Nachrichten (2014) (0)
- Expertenkonsensus zur Prophylaxebehandlung des hereditären Angioödems (2022) (0)
- Einflüsse des Tenors der Medienberichterstattung auf wahlrelevante Urteile (2013) (0)
- Dermatologie und Venerologie (2014) (0)
- Die Wahrnehmung des zweiten TV-Duells (2003) (0)
- Nonverbale Kommunikation in den Massenmedien (2016) (0)
- Epilog: Die Zukunft der Fernsehdebatten in Deutschland (2003) (0)
- Mastzellen und Basophile (2016) (0)
- 17. Mainzer Allergie-Workshop (2005) (0)
- Neue Therapeutika beim Hereditären Angioödem unbeantwortete Fragen beim Hereditären Angioödem (2013) (0)
- Bisher in der Reihe erschienene Bände (2017) (0)
- 6. Verwandte / konkurrierende Ansätze (2010) (0)
- Fazit: Die Bedeutung nonverbaler Kommunikation in der Politik (2016) (0)
- 12 Erkrankungen der Schweißdrüsen (2014) (0)
- 17 Physikalische und chemische Hautschäden: Licht, Elektrizität, Temperatur und chemische Agenzien (2014) (0)
- 18.3 Porphyrien, Lipid- und Speicherkrankheiten, Amyloidosen, Ernährungsstörungen (2014) (0)
- 8.1 Epitheliale Tumoren (2014) (0)
- 8.2 Melanozytäre Tumoren (2014) (0)
- Chronische autoreaktive Urtikaria (2011) (0)
- Rote und juckende bilaterale supraorbitale Schwellungen (2018) (0)
- 8.6 Histiozytosen (2014) (0)
- Neue Leitlinien für Urtikaria und hereditäre Angioödeme – was ändert sich? was bleibt gleich? (2019) (0)
- Rechnerwerkzeuge für die Planung von individuellen Produkten (2004) (0)
- Wie Phoenix aus der Asche (2006) (0)
- 1.6 Intoleranzreaktionen auf Nahrungsmittel (2014) (0)
- Atopische Dermatitis und allergische Rhinitis ‐ gibt es Co‐Effekte in der Therapie? (2012) (0)
- Evolutionsbiologische und soziokulturelle Ansätze zur Erklärung nonverbalen Verhaltens (2016) (0)
- 5.1 Pemphigus-Gruppe (2014) (0)
- 19 Hereditäre Hauterkrankungen (2014) (0)
- Innovationsperspektiven für die Wissenschaft und Praxis der Verkehrssicherheitskommunikation (2015) (0)
- 5.2 Pemphigoid-Gruppe (2014) (0)
- Urtikaria und atopisches Ekzem (V 50–V 57) (2000) (0)
- Medienwirkungen auf Einstellungen zu politischen Themen und Akteuren (2020) (0)
- Patienten mit chronischer spontaner Urtikaria sind noch nicht ausreichend behandelt: 1 Jahres-Daten der AWARE Studie (2018) (0)
- Aktuelle wissenschaftliche Erkenntnisse zur Mastzelle : Bedeutung für die Praxis (2007) (0)
- Rolle der Mastzelle bei allergischem Asthma bronchiale (2008) (0)
- Der mediale Attraktivitätsbonus. Zum Einfluss der Attraktivität von Wahlkreiskandidaten auf die Medienberichterstattung (2010) (0)
- 18.2 Schwangerschaftsdermatosen (2014) (0)
- Die Wahrnehmung verbaler und nonverbaler Kommunikation (2016) (0)
- Rezeption und Wirkung einer längerfristigen Kampagne: Runter vom Gas!, 2008 bis 2010 (2015) (0)
- 4.4 Autoinflammation, neutrophilen- und eosinophilenreiche Dermatosen (2014) (0)
- Die Wirkungen verbaler und nonverbaler politischer Kommunikation im Vergleich (2016) (0)
- Grenzen der Wirksamkeit präventiver Botschaften am Beispiel von Verkehrssicherheitskampagnen (2015) (0)
- Theorieansätze und Hypothesen in der Medienpädagogik: Agenda-Setting (2020) (0)
- Die Zuschauer der TV-Duelle (2003) (0)
- 7.Fazit: Die gesellschaftliche Relevanz des Agenda-Setting- Effekts (2010) (0)
- Die Inhalte des zweiten TV-Duells und der Medienberichte (2003) (0)
- Gerät zur standardisierten Temperaturexposition auf der Haut von Patienten mit Kälte- bzw. Wärmeurtikaria (2001) (0)
- Notes from the Arbeitsgemeinschaft Dermatologische Forschung (ADF), Berlin (2009) (0)
- Praktische Tipps für die Betreuung von Patienten mit Urtikaria (2007) (0)
- Was gibt es Neues in der Forschung (2011) (0)
- Medien über die Corona-Pandemie (2022) (0)
- Erratum zu: Diagnostik und Ausschluss des hereditären Angioödems (2012) (0)
- PPIASE DOMAIN OF THE MYCOPLASMA GENITALIUM TRIGGER FACTOR (2002) (0)
- Rapid identification of human mast cell degranulation regulators using functional genomics coupled to high-resolution confocal microscopy (2020) (0)
- P65: Retrospective analysis of the safety and appropriate use of 2,3‐diphenylcyclopropenone in alopecia in a university teaching hospital (2021) (0)
- PSY6 THE ICATIBANT OUTCOME SURVEY:A PROSPECTIVE STUDY OF SAFETY AND EFFECTIVENESS OF ICATIBANT IN A ‘REAL WORLD' SETTING IN PATIENTS WITH HEREDITARY ANGIOEDEMA (2010) (0)
- Contents Vol. 226, 2013 (2013) (0)
- Schnitzler 综合征与 CCL2 (2019) (0)
- Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric (2005) (0)
- Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA‐MeDALL hypothesis (2023) (0)
- P67: High rate of complete response with ligelizumab in adults with moderate‐to‐severe chronic spontaneous urticaria (2021) (0)
- Short title: An online survey of chronic urticaria patients highlighting unmet clinical needs (2015) (0)
- University of Southern Denmark Oral plasma kallikrein inhibitor for prophylaxis in hereditary angioedema Aygören-Pürsün, (2018) (0)
- Issue Information (2021) (0)
- Therapy of urticaria: German language version of the international S3-guideline (2012) (0)
- CCL2 in Schnitzler syndrome (2019) (0)
- 8.7 Mastozytosen (2014) (0)
- Wytyczne EAACI/GA2LEN/EDF/WAO dotyczące definicji, klasyfikacji, rozpoznawania i leczenia pokrzywki: weryfikacja z 2013 roku z poprawkami (2015) (0)
- PCC o dużej zawartości części stałych z dodatkiem kopolimerowym (2015) (0)
- 2.5 Epizoonosen (2014) (0)
- Granulozyten (V 15–V 22) (2000) (0)
- REMIBRUTINIB IMPROVES CHRONIC SPONTANEOUS URTICARIA IN PATIENTS IRRESPECTIVE OF CU-INDEX: RESULTS FROM PHASE 2B STUDY (2022) (0)
- FREEDOM FROM ITCH AND HIVES IN CHRONIC SPONTANEOUS URTICARIA IS ASSOCIATED WITH IMPROVED QUALITY-OF-LIFE MEASURES (2022) (0)
- SUSTAINED IMPROVEMENT IN HEALTH-RELATED QUALITY OF LIFE WITH CONTINUED LANADELUMAB TREATMENT IN HEREDITARY ANGIOEDEMA (2022) (0)
- P047 COMPLETE RESPONSE WITH LIGELIZUMAB IN CHRONIC SPONTANEOUS URTICARIA: A COMPOSITE SCORE OF SYMPTOMS AND QUALITY-OF-LIFE (2021) (0)
- P049 LIGELIZUMAB ACHIEVES FREEDOM FROM DISEASE ACTIVITY IN CHRONIC SPONTANEOUS URTICARIA REGARDLESS OF PREVIOUS H1-ANTIHISTAMINE DOSE (2021) (0)
- REMIBRUTINIB IMPROVES CHRONIC SPONTANEOUS URTICARIA IN PATIENTS WITH LOW OR HIGH IGE (2022) (0)
- BARRIERS OF USE OF PROMS AMONG ALLERGISTS WHO TREAT ATOPIC DERMATITIS AND CHRONIC URTICARIA (2022) (0)
- REMIBRUTINIB TREATMENT IMPROVES SLEEP AND ACTIVITY IN CHRONIC SPONTANEOUS URTICARIA PATIENTS: PHASE 2B STUDY RESULTS (2022) (0)
- Bispecific CD8 Treg modulators regulate a novel regulatory CD8 T cell network and eliminate pathogenic CD4 T cells in live cell co-culture system (2022) (0)
- Label-free imaging of M1 and M2 macrophage phenotypes in the human dermis in vivo 1 using two-photon excited FLIM 2 (0)
- A NOVEL BISPECIFIC CD8 TREG MODULATOR TARGETING CYTOLYTIC CD8 REGULATORY T CELLS REDUCES PATHOGENIC CD4 T CELLS AND INFLAMMATION IN TRANSLATIONAL MODELS OF INTESTINAL AUTOIMMUNE AND INFLAMMATORY DISEASE (2023) (0)
- Sa1117: A NEWLY DISCOVERED REGULATORY CD8 T CELL NETWORK HAS THE POTENTIAL TO REGULATE AND ELIMINATE PATHOGENIC CD4 T CELLS IN AUTOIMMUNE MEDIATED DIGESTIVE DISEASE (2022) (0)
- Demonstration of regulatory CD8 T cell prevalence, phenotype, and functions in autoimmune patients treated with a tolerizing peptide vaccine. (2022) (0)
- A NEWLY DISCOVERED REGULATORY CD8 T CELL NETWORK HAS THE POTENTIAL TO REGULATE AND ELIMINATE PATHOGENIC CD4 T CELLS IN AUTOIMMUNE MEDIATED DISEASE OF THE GUT (2022) (0)
- Recurrent Angio‐Oedema without Weals (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Marcus Maurer?
Marcus Maurer is affiliated with the following schools:
